,gene_id,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,X6_1,X7_1,X8_1,X9_1,X21_1,X22_1,X23_1,X25_1,X26_1,X27_1,X29_1,X34_1,length,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,Treatment_Compare
1,jamg1.model.Sc0000051.45,GO:0051225,0.01120444,0.999490557,2,13,spindle assembly,BP,604,130,81,141,152,157,182,484,422,98,126,71,402,175.2670233,0.635514209,0.172971923,3.674088825,0.0002387,0.035957066,CvsMid
2,jamg1.model.Sc0000051.45,GO:0007052,0.028261158,0.997783944,2,23,mitotic spindle organization,BP,604,130,81,141,152,157,182,484,422,98,126,71,402,175.2670233,0.635514209,0.172971923,3.674088825,0.0002387,0.035957066,CvsMid
3,jamg1.model.Sc0000051.45,GO:0018105,0.020122829,0.997343127,3,58,peptidyl-serine phosphorylation,BP,604,130,81,141,152,157,182,484,422,98,126,71,402,175.2670233,0.635514209,0.172971923,3.674088825,0.0002387,0.035957066,CvsMid
4,jamg1.model.Sc0000051.45,GO:1904743,0.039470849,0.999474787,1,3,negative regulation of telomeric DNA binding,BP,604,130,81,141,152,157,182,484,422,98,126,71,402,175.2670233,0.635514209,0.172971923,3.674088825,0.0002387,0.035957066,CvsMid
5,jamg1.model.Sc0000051.45,GO:0045944,0.044572701,0.983625155,7,327,positive regulation of transcription by RNA polymerase II,BP,604,130,81,141,152,157,182,484,422,98,126,71,402,175.2670233,0.635514209,0.172971923,3.674088825,0.0002387,0.035957066,CvsMid
6,jamg1.model.Sc0000055.95,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,35,8,10,8,116,6,6,24,17,10,73,5,3270,24.62347917,2.650623071,0.596770036,4.441615546,8.93E-06,0.019317022,MidvsHigh
7,jamg1.model.Sc0000055.95,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,35,8,10,8,116,6,6,24,17,10,73,5,3270,24.62347917,-2.297504958,0.56452999,-4.069765994,4.71E-05,0.009771389,CvsMid
8,jamg1.model.Sc0000055.95,GO:0016647,0.025781328,0.999777326,1,3,"oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor",MF,35,8,10,8,116,6,6,24,17,10,73,5,3270,24.62347917,2.650623071,0.596770036,4.441615546,8.93E-06,0.019317022,MidvsHigh
9,jamg1.model.Sc0000055.95,GO:0016647,0.025781328,0.999777326,1,3,"oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor",MF,35,8,10,8,116,6,6,24,17,10,73,5,3270,24.62347917,-2.297504958,0.56452999,-4.069765994,4.71E-05,0.009771389,CvsMid
10,jamg1.model.Sc0000101.46,GO:0001729,0.014554175,1,1,1,ceramide kinase activity,MF,197,103,31,24,79,157,78,153,89,97,63,36,909,83.71844869,-1.126112918,0.281226069,-4.00429776,6.22E-05,0.013793571,CvsHigh
11,jamg1.model.Sc0000117.30,GO:0070652,0.0290973,0.999715933,1,3,HAUS complex,CC,261,115,143,68,275,170,150,274,145,148,209,73,5229,163.9529618,-1.146763458,0.229758105,-4.991177395,6.00E-07,0.000271203,CvsMid
12,jamg1.model.Sc0000117.30,GO:0051225,0.01120444,0.999490557,2,13,spindle assembly,BP,261,115,143,68,275,170,150,274,145,148,209,73,5229,163.9529618,-1.146763458,0.229758105,-4.991177395,6.00E-07,0.000271203,CvsMid
13,jamg1.model.Sc0000117.30,GO:0072686,0.03858638,0.993418674,3,74,mitotic spindle,CC,261,115,143,68,275,170,150,274,145,148,209,73,5229,163.9529618,-1.146763458,0.229758105,-4.991177395,6.00E-07,0.000271203,CvsMid
14,jamg1.model.Sc0000225.27,GO:0009949,0.021991989,0.999878538,1,2,polarity specification of anterior/posterior axis,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
15,jamg1.model.Sc0000225.27,GO:0044335,0.041911897,0.999333838,1,4,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
16,jamg1.model.Sc0000225.27,GO:0035282,0.038262148,0.999445681,1,4,segmentation,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
17,jamg1.model.Sc0000225.27,GO:2000044,0.014964977,1,1,1,negative regulation of cardiac cell fate specification,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
18,jamg1.model.Sc0000225.27,GO:0048561,0.014964977,1,1,1,establishment of animal organ orientation,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
19,jamg1.model.Sc0000225.27,GO:0040011,0.012369884,0.99864808,3,47,locomotion,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
20,jamg1.model.Sc0000225.27,GO:0045944,0.044572701,0.983625155,7,327,positive regulation of transcription by RNA polymerase II,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
21,jamg1.model.Sc0000225.27,GO:0001654,0.001623067,0.999918285,3,23,eye development,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
22,jamg1.model.Sc0000225.27,GO:0060061,0.03872187,0.999432168,1,4,Spemann organizer formation,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
23,jamg1.model.Sc0000225.27,GO:0060788,0.038352051,0.999443052,1,4,ectodermal placode formation,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
24,jamg1.model.Sc0000225.27,GO:0010085,0.023970554,0.999855554,1,2,polarity specification of proximal/distal axis,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
25,jamg1.model.Sc0000225.27,GO:0002020,0.043298595,0.995631196,2,34,protease binding,MF,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
26,jamg1.model.Sc0000225.27,GO:0000578,0.03784146,0.999457902,1,4,embryonic axis specification,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
27,jamg1.model.Sc0000225.27,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
28,jamg1.model.Sc0000225.27,GO:0061317,0.014964977,1,1,1,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
29,jamg1.model.Sc0000225.27,GO:0062009,0.029755393,0.999702848,1,3,secondary palate development,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
30,jamg1.model.Sc0000225.27,GO:0021999,0.02861052,0.99979373,1,2,neural plate anterior/posterior regionalization,BP,1339,519,227,118,635,731,740,697,519,577,431,289,870,524.4360544,-1.229896511,0.261498906,-4.703256821,2.56E-06,0.001063275,CvsHigh
31,jamg1.model.Sc0000225.29,GO:0040012,0.008186208,0.999683944,2,13,regulation of locomotion,BP,812,308,165,86,330,429,506,451,363,344,275,231,597,337.2538535,-1.13687431,0.264103993,-4.304646433,1.67E-05,0.005038896,CvsHigh
32,jamg1.model.Sc0000551.3,GO:0006491,0.039878479,0.999397439,1,4,N-glycan processing,BP,35,18,20,3,52,20,25,10,8,31,27,13,1710,22.93994059,-2.356621914,0.415569532,-5.670824579,1.42E-08,1.04E-05,CvsMid
33,jamg1.model.Sc0000551.3,GO:0006491,0.039878479,0.999397439,1,4,N-glycan processing,BP,35,18,20,3,52,20,25,10,8,31,27,13,1710,22.93994059,-1.999720223,0.416356852,-4.802899753,1.56E-06,0.000800948,CvsHigh
34,jamg1.model.Sc0000551.3,GO:0004571,0.017888094,0.999919809,1,2,"mannosyl-oligosaccharide 1,2-alpha-mannosidase activity",MF,35,18,20,3,52,20,25,10,8,31,27,13,1710,22.93994059,-2.356621914,0.415569532,-5.670824579,1.42E-08,1.04E-05,CvsMid
35,jamg1.model.Sc0000551.3,GO:0004571,0.017888094,0.999919809,1,2,"mannosyl-oligosaccharide 1,2-alpha-mannosidase activity",MF,35,18,20,3,52,20,25,10,8,31,27,13,1710,22.93994059,-1.999720223,0.416356852,-4.802899753,1.56E-06,0.000800948,CvsHigh
36,jamg1.model.Sc0000551.3,GO:0036509,0.008984143,1,1,1,trimming of terminal mannose on B branch,BP,35,18,20,3,52,20,25,10,8,31,27,13,1710,22.93994059,-2.356621914,0.415569532,-5.670824579,1.42E-08,1.04E-05,CvsMid
37,jamg1.model.Sc0000551.3,GO:0036509,0.008984143,1,1,1,trimming of terminal mannose on B branch,BP,35,18,20,3,52,20,25,10,8,31,27,13,1710,22.93994059,-1.999720223,0.416356852,-4.802899753,1.56E-06,0.000800948,CvsHigh
38,jamg1.model.Sc0000551.3,GO:1904382,0.017888094,0.999919809,1,2,mannose trimming involved in glycoprotein ERAD pathway,BP,35,18,20,3,52,20,25,10,8,31,27,13,1710,22.93994059,-2.356621914,0.415569532,-5.670824579,1.42E-08,1.04E-05,CvsMid
39,jamg1.model.Sc0000551.3,GO:1904382,0.017888094,0.999919809,1,2,mannose trimming involved in glycoprotein ERAD pathway,BP,35,18,20,3,52,20,25,10,8,31,27,13,1710,22.93994059,-1.999720223,0.416356852,-4.802899753,1.56E-06,0.000800948,CvsHigh
40,jamg1.model.Sc0000654.3,GO:2000299,0.03808967,0.999511211,1,3,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,17,28,9,4,30,12,17,10,12,8,20,10,1116,15.19323648,-1.662393424,0.421648006,-3.942609474,8.06E-05,0.016735359,CvsHigh
41,jamg1.model.Sc0000654.3,GO:2000299,0.03808967,0.999511211,1,3,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,17,28,9,4,30,12,17,10,12,8,20,10,1116,15.19323648,-1.931220689,0.422249693,-4.573646163,4.79E-06,0.001544453,CvsMid
42,jamg1.model.Sc0000654.3,GO:1905709,0.03808967,0.999511211,1,3,negative regulation of membrane permeability,BP,17,28,9,4,30,12,17,10,12,8,20,10,1116,15.19323648,-1.662393424,0.421648006,-3.942609474,8.06E-05,0.016735359,CvsHigh
43,jamg1.model.Sc0000654.3,GO:1905709,0.03808967,0.999511211,1,3,negative regulation of membrane permeability,BP,17,28,9,4,30,12,17,10,12,8,20,10,1116,15.19323648,-1.931220689,0.422249693,-4.573646163,4.79E-06,0.001544453,CvsMid
44,jamg1.model.Sc0000654.3,GO:0030324,0.01541899,0.998160495,3,55,lung development,BP,17,28,9,4,30,12,17,10,12,8,20,10,1116,15.19323648,-1.662393424,0.421648006,-3.942609474,8.06E-05,0.016735359,CvsHigh
45,jamg1.model.Sc0000654.3,GO:0030324,0.01541899,0.998160495,3,55,lung development,BP,17,28,9,4,30,12,17,10,12,8,20,10,1116,15.19323648,-1.931220689,0.422249693,-4.573646163,4.79E-06,0.001544453,CvsMid
46,jamg1.model.Sc0000654.3,GO:0035024,0.019136123,0.998798626,2,19,negative regulation of Rho protein signal transduction,BP,17,28,9,4,30,12,17,10,12,8,20,10,1116,15.19323648,-1.662393424,0.421648006,-3.942609474,8.06E-05,0.016735359,CvsHigh
47,jamg1.model.Sc0000654.3,GO:0035024,0.019136123,0.998798626,2,19,negative regulation of Rho protein signal transduction,BP,17,28,9,4,30,12,17,10,12,8,20,10,1116,15.19323648,-1.931220689,0.422249693,-4.573646163,4.79E-06,0.001544453,CvsMid
48,jamg1.model.xfSc0000800.1,GO:0001654,0.001623067,0.999918285,3,23,eye development,BP,29,17,15,8,48,11,13,17,10,10,29,7,1683,17.48474185,-1.821912475,0.38119516,-4.779474308,1.76E-06,0.000741426,CvsMid
49,jamg1.model.xfSc0000800.1,GO:0005575,0.03213374,0.991382616,5,178,cellular_component,CC,29,17,15,8,48,11,13,17,10,10,29,7,1683,17.48474185,-1.821912475,0.38119516,-4.779474308,1.76E-06,0.000741426,CvsMid
50,jamg1.model.xfSc0000800.1,GO:0003674,0.021909676,0.993808785,6,219,molecular_function,MF,29,17,15,8,48,11,13,17,10,10,29,7,1683,17.48474185,-1.821912475,0.38119516,-4.779474308,1.76E-06,0.000741426,CvsMid
51,jamg1.model.xpSc0007059.15,GO:0007059,0.020076301,0.998696671,2,21,chromosome segregation,BP,25,26,14,7,25,13,19,18,13,16,15,11,798,17.17652117,-1.338550344,0.35663483,-3.753279913,0.000174536,0.028529172,CvsMid
52,jamg1.model.xpSc0007059.15,GO:0007059,0.020076301,0.998696671,2,21,chromosome segregation,BP,25,26,14,7,25,13,19,18,13,16,15,11,798,17.17652117,-1.317065139,0.349066225,-3.77310964,0.000161225,0.030965352,CvsHigh
53,jamg1.model.xpSc0007059.15,GO:0007052,0.028261158,0.997783944,2,23,mitotic spindle organization,BP,25,26,14,7,25,13,19,18,13,16,15,11,798,17.17652117,-1.338550344,0.35663483,-3.753279913,0.000174536,0.028529172,CvsMid
54,jamg1.model.xpSc0007059.15,GO:0007052,0.028261158,0.997783944,2,23,mitotic spindle organization,BP,25,26,14,7,25,13,19,18,13,16,15,11,798,17.17652117,-1.317065139,0.349066225,-3.77310964,0.000161225,0.030965352,CvsHigh
55,jamg1.model.xpSc0007059.15,GO:0031262,0.031010678,0.999677062,1,3,Ndc80 complex,CC,25,26,14,7,25,13,19,18,13,16,15,11,798,17.17652117,-1.338550344,0.35663483,-3.753279913,0.000174536,0.028529172,CvsMid
56,jamg1.model.xpSc0007059.15,GO:0031262,0.031010678,0.999677062,1,3,Ndc80 complex,CC,25,26,14,7,25,13,19,18,13,16,15,11,798,17.17652117,-1.317065139,0.349066225,-3.77310964,0.000161225,0.030965352,CvsHigh
57,plut2.m8.1011,GO:0051638,0.026548309,0.999822582,1,2,barbed-end actin filament uncapping,BP,2102,805,611,214,842,803,1147,986,1057,1069,931,521,609,880.8114523,-1.080374428,0.26459582,-4.083112234,4.44E-05,0.010504116,CvsHigh
58,plut2.m8.1011,GO:0030032,0.008254256,0.999676846,2,14,lamellipodium assembly,BP,2102,805,611,214,842,803,1147,986,1057,1069,931,521,609,880.8114523,-1.080374428,0.26459582,-4.083112234,4.44E-05,0.010504116,CvsHigh
59,plut2.m8.1011,GO:0030027,0.023672016,0.996676695,3,58,lamellipodium,CC,2102,805,611,214,842,803,1147,986,1057,1069,931,521,609,880.8114523,-1.080374428,0.26459582,-4.083112234,4.44E-05,0.010504116,CvsHigh
60,plut2.m8.1011,GO:1902745,0.026548309,0.999822582,1,2,positive regulation of lamellipodium organization,BP,2102,805,611,214,842,803,1147,986,1057,1069,931,521,609,880.8114523,-1.080374428,0.26459582,-4.083112234,4.44E-05,0.010504116,CvsHigh
61,plut2.m8.1011,GO:0051639,0.049385607,0.999011052,1,5,actin filament network formation,BP,2102,805,611,214,842,803,1147,986,1057,1069,931,521,609,880.8114523,-1.080374428,0.26459582,-4.083112234,4.44E-05,0.010504116,CvsHigh
62,plut2.m8.1011,GO:0046415,0.044489809,0.999331179,1,3,urate metabolic process,BP,2102,805,611,214,842,803,1147,986,1057,1069,931,521,609,880.8114523,-1.080374428,0.26459582,-4.083112234,4.44E-05,0.010504116,CvsHigh
63,plut2.m8.1011,GO:2000813,0.031983971,0.99965632,1,3,negative regulation of barbed-end actin filament capping,BP,2102,805,611,214,842,803,1147,986,1057,1069,931,521,609,880.8114523,-1.080374428,0.26459582,-4.083112234,4.44E-05,0.010504116,CvsHigh
64,plut2.m8.10411,GO:0055067,0.038600592,0.999398529,1,5,monovalent inorganic cation homeostasis,BP,481,199,369,163,242,390,466,384,281,296,540,355,3697,380.6992161,-1.599185928,0.355522871,-4.498123918,6.86E-06,0.002147226,CvsMid
65,plut2.m8.10411,GO:0072234,0.038600592,0.999398529,1,5,metanephric nephron tubule development,BP,481,199,369,163,242,390,466,384,281,296,540,355,3697,380.6992161,-1.599185928,0.355522871,-4.498123918,6.86E-06,0.002147226,CvsMid
66,plut2.m8.10411,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,481,199,369,163,242,390,466,384,281,296,540,355,3697,380.6992161,-1.599185928,0.355522871,-4.498123918,6.86E-06,0.002147226,CvsMid
67,plut2.m8.10671,GO:0033683,0.022501559,0.999872811,1,2,"nucleotide-excision repair, DNA incision",BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
68,plut2.m8.10671,GO:0033683,0.022501559,0.999872811,1,2,"nucleotide-excision repair, DNA incision",BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
69,plut2.m8.10671,GO:0040016,0.002484953,0.999954386,2,7,embryonic cleavage,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
70,plut2.m8.10671,GO:0040016,0.002484953,0.999954386,2,7,embryonic cleavage,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
71,plut2.m8.10671,GO:0060218,0.008446077,0.999662603,2,15,hematopoietic stem cell differentiation,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
72,plut2.m8.10671,GO:0060218,0.008446077,0.999662603,2,15,hematopoietic stem cell differentiation,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
73,plut2.m8.10671,GO:0000717,0.015494047,1,1,1,"nucleotide-excision repair, DNA duplex unwinding",BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
74,plut2.m8.10671,GO:0000717,0.015494047,1,1,1,"nucleotide-excision repair, DNA duplex unwinding",BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
75,plut2.m8.10671,GO:0006362,0.015494047,1,1,1,transcription elongation from RNA polymerase I promoter,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
76,plut2.m8.10671,GO:0006362,0.015494047,1,1,1,transcription elongation from RNA polymerase I promoter,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
77,plut2.m8.10671,GO:0043249,0.0352962,0.999580816,1,3,erythrocyte maturation,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
78,plut2.m8.10671,GO:0043249,0.0352962,0.999580816,1,3,erythrocyte maturation,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
79,plut2.m8.10671,GO:0048568,0.020394238,0.998656131,2,23,embryonic organ development,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
80,plut2.m8.10671,GO:0048568,0.020394238,0.998656131,2,23,embryonic organ development,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
81,plut2.m8.10671,GO:0032289,0.037059212,0.99953752,1,3,central nervous system myelin formation,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
82,plut2.m8.10671,GO:0032289,0.037059212,0.99953752,1,3,central nervous system myelin formation,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
83,plut2.m8.10671,GO:0000112,0.015494047,1,1,1,nucleotide-excision repair factor 3 complex,CC,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
84,plut2.m8.10671,GO:0000112,0.015494047,1,1,1,nucleotide-excision repair factor 3 complex,CC,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
85,plut2.m8.10671,GO:0006283,0.046646858,0.999173124,1,4,transcription-coupled nucleotide-excision repair,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
86,plut2.m8.10671,GO:0006283,0.046646858,0.999173124,1,4,transcription-coupled nucleotide-excision repair,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
87,plut2.m8.10671,GO:0071817,0.038730836,0.999494468,1,3,MMXD complex,CC,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
88,plut2.m8.10671,GO:0071817,0.038730836,0.999494468,1,3,MMXD complex,CC,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
89,plut2.m8.10671,GO:0043388,0.002776444,0.999946059,2,7,positive regulation of DNA binding,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
90,plut2.m8.10671,GO:0043388,0.002776444,0.999946059,2,7,positive regulation of DNA binding,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
91,plut2.m8.10671,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
92,plut2.m8.10671,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
93,plut2.m8.10671,GO:0005675,0.041899828,0.999334225,1,4,transcription factor TFIIH holo complex,CC,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
94,plut2.m8.10671,GO:0005675,0.041899828,0.999334225,1,4,transcription factor TFIIH holo complex,CC,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
95,plut2.m8.10671,GO:0043139,0.00322257,0.999929818,2,8,5'-3' DNA helicase activity,MF,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
96,plut2.m8.10671,GO:0043139,0.00322257,0.999929818,2,8,5'-3' DNA helicase activity,MF,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
97,plut2.m8.10671,GO:0045951,0.022495091,0.999872885,1,2,positive regulation of mitotic recombination,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
98,plut2.m8.10671,GO:0045951,0.022495091,0.999872885,1,2,positive regulation of mitotic recombination,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
99,plut2.m8.10671,GO:0007059,0.020076301,0.998696671,2,21,chromosome segregation,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-1.923426966,0.382122228,-5.033538547,4.82E-07,0.000224193,CvsMid
100,plut2.m8.10671,GO:0007059,0.020076301,0.998696671,2,21,chromosome segregation,BP,16,16,13,5,26,21,21,13,8,22,18,9,821,16.86619457,-2.029422588,0.371840997,-5.457769863,4.82E-08,3.37E-05,CvsHigh
101,plut2.m8.11052,GO:0038061,0.037878252,0.999456839,1,4,NIK/NF-kappaB signaling,BP,156,20,76,58,30,9,7,77,161,6,28,42,2664,49.36795859,2.489789467,0.524040837,4.751136348,2.02E-06,0.000930568,CvsHigh
102,plut2.m8.11052,GO:0038061,0.037878252,0.999456839,1,4,NIK/NF-kappaB signaling,BP,156,20,76,58,30,9,7,77,161,6,28,42,2664,49.36795859,2.532751212,0.52939168,4.784267124,1.72E-06,0.007425666,MidvsHigh
103,plut2.m8.11052,GO:0051707,0.049013967,0.994714315,2,33,response to other organism,BP,156,20,76,58,30,9,7,77,161,6,28,42,2664,49.36795859,2.489789467,0.524040837,4.751136348,2.02E-06,0.000930568,CvsHigh
104,plut2.m8.11052,GO:0051707,0.049013967,0.994714315,2,33,response to other organism,BP,156,20,76,58,30,9,7,77,161,6,28,42,2664,49.36795859,2.532751212,0.52939168,4.784267124,1.72E-06,0.007425666,MidvsHigh
105,plut2.m8.11877,GO:0071630,0.035161542,0.999584034,1,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
106,plut2.m8.11877,GO:0017145,0.034965361,0.999588699,1,3,stem cell division,BP,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
107,plut2.m8.11877,GO:0044346,0.025153254,0.999840852,1,2,fibroblast apoptotic process,BP,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
108,plut2.m8.11877,GO:0001831,0.034066289,0.99960974,1,3,trophectodermal cellular morphogenesis,BP,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
109,plut2.m8.11877,GO:0007229,0.015215116,0.999153664,2,19,integrin-mediated signaling pathway,BP,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
110,plut2.m8.11877,GO:0043149,0.03934984,0.999413443,1,4,stress fiber assembly,BP,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
111,plut2.m8.11877,GO:0005112,0.001256689,0.999942694,3,21,Notch binding,MF,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
112,plut2.m8.11877,GO:0030332,0.006579192,0.999770985,2,14,cyclin binding,MF,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
113,plut2.m8.11877,GO:0005827,0.032996541,0.999634045,1,3,polar microtubule,CC,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
114,plut2.m8.11877,GO:0016477,0.002553513,0.999635491,5,96,cell migration,BP,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
115,plut2.m8.11877,GO:0036126,0.034429864,0.996950332,2,30,sperm flagellum,CC,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
116,plut2.m8.11877,GO:0040016,0.002484953,0.999954386,2,7,embryonic cleavage,BP,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
117,plut2.m8.11877,GO:0072686,0.03858638,0.993418674,3,74,mitotic spindle,CC,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
118,plut2.m8.11877,GO:0035024,0.019136123,0.998798626,2,19,negative regulation of Rho protein signal transduction,BP,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
119,plut2.m8.11877,GO:0031208,0.048451022,0.999107226,1,4,POZ domain binding,MF,35,36,11,8,36,16,19,18,19,23,17,7,948,19.65820509,-1.33614768,0.362555151,-3.685363943,0.000228376,0.040333312,CvsHigh
120,plut2.m8.1212,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,682,223,85,97,162,170,240,461,413,121,75,53,2664,180.4850045,0.782628119,0.218968438,3.574159473,0.000351355,0.049528126,CvsMid
121,plut2.m8.1212,GO:0002020,0.043298595,0.995631196,2,34,protease binding,MF,682,223,85,97,162,170,240,461,413,121,75,53,2664,180.4850045,0.782628119,0.218968438,3.574159473,0.000351355,0.049528126,CvsMid
122,plut2.m8.1221,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,18,43,15,3,32,18,19,10,12,14,25,14,2343,20.06409085,-2.314207757,0.406290722,-5.695940453,1.23E-08,9.92E-06,CvsMid
123,plut2.m8.1221,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,18,43,15,3,32,18,19,10,12,14,25,14,2343,20.06409085,-2.221626268,0.402025872,-5.526077854,3.27E-08,2.64E-05,CvsHigh
124,plut2.m8.12217,GO:0008297,0.04868319,0.999098558,1,4,single-stranded DNA exodeoxyribonuclease activity,MF,293,134,31,43,80,101,85,190,198,110,10,20,2172,86.59974378,-1.499102801,0.363798097,-4.120699954,3.78E-05,0.037717103,MidvsHigh
125,plut2.m8.12217,GO:0006264,0.002970756,0.999936181,2,9,mitochondrial DNA replication,BP,293,134,31,43,80,101,85,190,198,110,10,20,2172,86.59974378,-1.499102801,0.363798097,-4.120699954,3.78E-05,0.037717103,MidvsHigh
126,plut2.m8.12217,GO:0043504,0.001977759,0.999967691,2,7,mitochondrial DNA repair,BP,293,134,31,43,80,101,85,190,198,110,10,20,2172,86.59974378,-1.499102801,0.363798097,-4.120699954,3.78E-05,0.037717103,MidvsHigh
127,plut2.m8.15873,GO:0070901,0.026643561,0.999821297,1,2,mitochondrial tRNA methylation,BP,71,38,20,20,91,58,27,54,36,26,92,18,2278,44.4601418,-1.436264646,0.38240892,-3.755834584,0.000172765,0.028529172,CvsMid
128,plut2.m8.15873,GO:0009019,0.015512543,0.999939766,1,2,tRNA (guanine-N1-)-methyltransferase activity,MF,71,38,20,20,91,58,27,54,36,26,92,18,2278,44.4601418,-1.436264646,0.38240892,-3.755834584,0.000172765,0.028529172,CvsMid
129,plut2.m8.15873,GO:0030488,0.032457382,0.99960211,1,4,tRNA methylation,BP,71,38,20,20,91,58,27,54,36,26,92,18,2278,44.4601418,-1.436264646,0.38240892,-3.755834584,0.000172765,0.028529172,CvsMid
130,plut2.m8.15977,GO:0014033,0.03792525,0.999419554,1,5,neural crest cell differentiation,BP,41,29,15,6,38,18,35,13,22,13,25,14,3824,22.16710644,-1.486852362,0.363997213,-4.084790515,4.41E-05,0.009547205,CvsMid
131,plut2.m8.15977,GO:0014033,0.03792525,0.999419554,1,5,neural crest cell differentiation,BP,41,29,15,6,38,18,35,13,22,13,25,14,3824,22.16710644,-1.334200231,0.360769543,-3.698206395,0.000217128,0.039249135,CvsHigh
132,plut2.m8.15977,GO:0009723,0.003025668,0.999934389,2,9,response to ethylene,BP,41,29,15,6,38,18,35,13,22,13,25,14,3824,22.16710644,-1.486852362,0.363997213,-4.084790515,4.41E-05,0.009547205,CvsMid
133,plut2.m8.15977,GO:0009723,0.003025668,0.999934389,2,9,response to ethylene,BP,41,29,15,6,38,18,35,13,22,13,25,14,3824,22.16710644,-1.334200231,0.360769543,-3.698206395,0.000217128,0.039249135,CvsHigh
134,plut2.m8.16218,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,178,29,14,40,41,30,32,111,101,32,22,10,1739,39.96452333,1.048623884,0.25156894,4.168336051,3.07E-05,0.006832556,CvsMid
135,plut2.m8.16218,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,178,29,14,40,41,30,32,111,101,32,22,10,1739,39.96452333,1.048623884,0.25156894,4.168336051,3.07E-05,0.006832556,CvsMid
136,plut2.m8.16218,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,178,29,14,40,41,30,32,111,101,32,22,10,1739,39.96452333,1.048623884,0.25156894,4.168336051,3.07E-05,0.006832556,CvsMid
137,plut2.m8.16218,GO:0048568,0.020394238,0.998656131,2,23,embryonic organ development,BP,178,29,14,40,41,30,32,111,101,32,22,10,1739,39.96452333,1.048623884,0.25156894,4.168336051,3.07E-05,0.006832556,CvsMid
138,plut2.m8.1654,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,204,42,12,28,25,29,29,84,79,36,16,11,963,36.47910677,1.237713896,0.310038531,3.992129278,6.55E-05,0.013066766,CvsMid
139,plut2.m8.1654,GO:0004713,0.002387017,0.999579723,6,145,protein tyrosine kinase activity,MF,204,42,12,28,25,29,29,84,79,36,16,11,963,36.47910677,1.237713896,0.310038531,3.992129278,6.55E-05,0.013066766,CvsMid
140,plut2.m8.1654,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,204,42,12,28,25,29,29,84,79,36,16,11,963,36.47910677,1.237713896,0.310038531,3.992129278,6.55E-05,0.013066766,CvsMid
141,plut2.m8.1654,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,204,42,12,28,25,29,29,84,79,36,16,11,963,36.47910677,1.237713896,0.310038531,3.992129278,6.55E-05,0.013066766,CvsMid
142,plut2.m8.16587,GO:0003674,0.021909676,0.993808785,6,219,molecular_function,MF,39,22,26,15,70,21,20,39,40,15,43,13,2895,29.12601838,-1.338480371,0.304025394,-4.402528196,1.07E-05,0.002884217,CvsMid
143,plut2.m8.16587,GO:0005575,0.03213374,0.991382616,5,178,cellular_component,CC,39,22,26,15,70,21,20,39,40,15,43,13,2895,29.12601838,-1.338480371,0.304025394,-4.402528196,1.07E-05,0.002884217,CvsMid
144,plut2.m8.18568,GO:0044826,0.018596484,0.9999133,1,2,viral genome integration into host DNA,BP,50,53,49,25,54,22,49,34,25,36,40,23,2808,41.1090803,-1.507463261,0.352806861,-4.272771956,1.93E-05,0.00478441,CvsMid
145,plut2.m8.18568,GO:0075713,0.026948575,0.999756577,1,3,establishment of integrated proviral latency,BP,50,53,49,25,54,22,49,34,25,36,40,23,2808,41.1090803,-1.507463261,0.352806861,-4.272771956,1.93E-05,0.00478441,CvsMid
146,plut2.m8.19607,GO:0003700,0.045552954,0.988855755,4,129,DNA-binding transcription factor activity,MF,67,27,23,8,77,36,28,50,30,21,40,11,2155,31.66159706,-1.218292746,0.328084928,-3.713345674,0.000204537,0.032068513,CvsMid
147,plut2.m8.20146,GO:0010801,0.049250497,0.999016511,1,5,negative regulation of peptidyl-threonine phosphorylation,BP,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.322847798,0.358784719,-6.474210502,9.53E-11,9.76E-08,CvsMid
148,plut2.m8.20146,GO:0010801,0.049250497,0.999016511,1,5,negative regulation of peptidyl-threonine phosphorylation,BP,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.414284833,0.356363906,-6.774773746,1.25E-11,1.51E-08,CvsHigh
149,plut2.m8.20146,GO:0071900,0.049532279,0.999066496,1,4,regulation of protein serine/threonine kinase activity,BP,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.322847798,0.358784719,-6.474210502,9.53E-11,9.76E-08,CvsMid
150,plut2.m8.20146,GO:0071900,0.049532279,0.999066496,1,4,regulation of protein serine/threonine kinase activity,BP,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.414284833,0.356363906,-6.774773746,1.25E-11,1.51E-08,CvsHigh
151,plut2.m8.20146,GO:0030324,0.01541899,0.998160495,3,55,lung development,BP,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.322847798,0.358784719,-6.474210502,9.53E-11,9.76E-08,CvsMid
152,plut2.m8.20146,GO:0030324,0.01541899,0.998160495,3,55,lung development,BP,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.414284833,0.356363906,-6.774773746,1.25E-11,1.51E-08,CvsHigh
153,plut2.m8.20146,GO:1990752,0.045836766,0.999201875,1,4,microtubule end,CC,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.322847798,0.358784719,-6.474210502,9.53E-11,9.76E-08,CvsMid
154,plut2.m8.20146,GO:1990752,0.045836766,0.999201875,1,4,microtubule end,CC,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.414284833,0.356363906,-6.774773746,1.25E-11,1.51E-08,CvsHigh
155,plut2.m8.20146,GO:0030291,0.037613462,0.999523461,1,3,protein serine/threonine kinase inhibitor activity,MF,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.322847798,0.358784719,-6.474210502,9.53E-11,9.76E-08,CvsMid
156,plut2.m8.20146,GO:0030291,0.037613462,0.999523461,1,3,protein serine/threonine kinase inhibitor activity,MF,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.414284833,0.356363906,-6.774773746,1.25E-11,1.51E-08,CvsHigh
157,plut2.m8.20146,GO:0150013,0.014460734,1,1,1,negative regulation of neuron projection arborization,BP,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.322847798,0.358784719,-6.474210502,9.53E-11,9.76E-08,CvsMid
158,plut2.m8.20146,GO:0150013,0.014460734,1,1,1,negative regulation of neuron projection arborization,BP,93,99,66,10,84,132,124,21,57,71,96,73,918,86.00791636,-2.414284833,0.356363906,-6.774773746,1.25E-11,1.51E-08,CvsHigh
159,plut2.m8.20774,GO:0035063,0.014224335,1,1,1,nuclear speck organization,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
160,plut2.m8.20774,GO:0035063,0.014224335,1,1,1,nuclear speck organization,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
161,plut2.m8.20774,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
162,plut2.m8.20774,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
163,plut2.m8.20774,GO:0035092,0.014224335,1,1,1,sperm chromatin condensation,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
164,plut2.m8.20774,GO:0035092,0.014224335,1,1,1,sperm chromatin condensation,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
165,plut2.m8.20774,GO:0045944,0.044572701,0.983625155,7,327,positive regulation of transcription by RNA polymerase II,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
166,plut2.m8.20774,GO:0045944,0.044572701,0.983625155,7,327,positive regulation of transcription by RNA polymerase II,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
167,plut2.m8.20774,GO:0016590,0.014224335,1,1,1,ACF complex,CC,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
168,plut2.m8.20774,GO:0016590,0.014224335,1,1,1,ACF complex,CC,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
169,plut2.m8.20774,GO:0042752,0.031423157,0.99736536,2,27,regulation of circadian rhythm,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
170,plut2.m8.20774,GO:0042752,0.031423157,0.99736536,2,27,regulation of circadian rhythm,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
171,plut2.m8.20774,GO:0035041,0.014224335,1,1,1,sperm chromatin decondensation,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
172,plut2.m8.20774,GO:0035041,0.014224335,1,1,1,sperm chromatin decondensation,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
173,plut2.m8.20774,GO:0008623,0.038909639,0.999426602,1,4,CHRAC,CC,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
174,plut2.m8.20774,GO:0008623,0.038909639,0.999426602,1,4,CHRAC,CC,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
175,plut2.m8.20774,GO:0031213,0.025130401,0.999841142,1,2,RSF complex,CC,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
176,plut2.m8.20774,GO:0031213,0.025130401,0.999841142,1,2,RSF complex,CC,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
177,plut2.m8.20774,GO:0035076,0.014224335,1,1,1,ecdysone receptor-mediated signaling pathway,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
178,plut2.m8.20774,GO:0035076,0.014224335,1,1,1,ecdysone receptor-mediated signaling pathway,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
179,plut2.m8.20774,GO:0005721,0.028981909,0.999718196,1,3,pericentric heterochromatin,CC,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
180,plut2.m8.20774,GO:0005721,0.028981909,0.999718196,1,3,pericentric heterochromatin,CC,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
181,plut2.m8.20774,GO:0046651,0.049264267,0.999015955,1,5,lymphocyte proliferation,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
182,plut2.m8.20774,GO:0046651,0.049264267,0.999015955,1,5,lymphocyte proliferation,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
183,plut2.m8.20774,GO:0006312,0.031820576,0.999659848,1,3,mitotic recombination,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
184,plut2.m8.20774,GO:0006312,0.031820576,0.999659848,1,3,mitotic recombination,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
185,plut2.m8.20774,GO:0006346,0.038672019,0.999496016,1,3,DNA methylation-dependent heterochromatin assembly,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
186,plut2.m8.20774,GO:0006346,0.038672019,0.999496016,1,3,DNA methylation-dependent heterochromatin assembly,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
187,plut2.m8.20774,GO:0031056,0.038721005,0.999432194,1,4,regulation of histone modification,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
188,plut2.m8.20774,GO:0031056,0.038721005,0.999432194,1,4,regulation of histone modification,BP,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
189,plut2.m8.20774,GO:0016589,0.022508493,0.999872732,1,2,NURF complex,CC,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.456292091,0.326101045,-4.465769475,7.98E-06,0.002357389,CvsMid
190,plut2.m8.20774,GO:0016589,0.022508493,0.999872732,1,2,NURF complex,CC,27,21,15,9,38,23,25,25,13,20,22,11,941,21.03140419,-1.345956868,0.321723898,-4.183577516,2.87E-05,0.007601892,CvsHigh
191,plut2.m8.20873,GO:0051724,0.011807868,1,1,1,NAD transmembrane transporter activity,MF,35,52,23,7,26,20,37,24,28,15,28,21,1203,27.31962489,-1.465204765,0.374926253,-3.907981243,9.31E-05,0.019067049,CvsHigh
192,plut2.m8.20873,GO:0051724,0.011807868,1,1,1,NAD transmembrane transporter activity,MF,35,52,23,7,26,20,37,24,28,15,28,21,1203,27.31962489,-1.448735094,0.380718991,-3.805260912,0.000141655,0.02418362,CvsMid
193,plut2.m8.20873,GO:0019646,0.011807868,1,1,1,aerobic electron transport chain,BP,35,52,23,7,26,20,37,24,28,15,28,21,1203,27.31962489,-1.465204765,0.374926253,-3.907981243,9.31E-05,0.019067049,CvsHigh
194,plut2.m8.20873,GO:0019646,0.011807868,1,1,1,aerobic electron transport chain,BP,35,52,23,7,26,20,37,24,28,15,28,21,1203,27.31962489,-1.448735094,0.380718991,-3.805260912,0.000141655,0.02418362,CvsMid
195,plut2.m8.20873,GO:1990549,0.011807868,1,1,1,mitochondrial NAD transmembrane transport,BP,35,52,23,7,26,20,37,24,28,15,28,21,1203,27.31962489,-1.465204765,0.374926253,-3.907981243,9.31E-05,0.019067049,CvsHigh
196,plut2.m8.20873,GO:1990549,0.011807868,1,1,1,mitochondrial NAD transmembrane transport,BP,35,52,23,7,26,20,37,24,28,15,28,21,1203,27.31962489,-1.448735094,0.380718991,-3.805260912,0.000141655,0.02418362,CvsMid
197,plut2.m8.21315,GO:0071476,0.035760072,0.99951633,1,4,cellular hypotonic response,BP,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
198,plut2.m8.21315,GO:0046713,0.007286888,1,1,1,borate transport,BP,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
199,plut2.m8.21315,GO:0015106,0.015405533,0.999940598,1,2,bicarbonate transmembrane transporter activity,MF,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
200,plut2.m8.21315,GO:2000739,0.014621855,0.999946509,1,2,regulation of mesenchymal stem cell differentiation,BP,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
201,plut2.m8.21315,GO:0005372,0.007286888,1,1,1,water transmembrane transporter activity,MF,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
202,plut2.m8.21315,GO:0005452,0.014860508,0.999944742,1,2,inorganic anion exchanger activity,MF,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
203,plut2.m8.21315,GO:0015701,0.015405533,0.999940598,1,2,bicarbonate transport,BP,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
204,plut2.m8.21315,GO:0042044,0.007286888,1,1,1,fluid transport,BP,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
205,plut2.m8.21315,GO:0051881,0.00586522,0.999811629,2,12,regulation of mitochondrial membrane potential,BP,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
206,plut2.m8.21315,GO:0030003,0.015492494,0.999939922,1,2,cellular cation homeostasis,BP,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
207,plut2.m8.21315,GO:0046715,0.007286888,1,1,1,active borate transmembrane transporter activity,MF,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
208,plut2.m8.21315,GO:0015252,0.007286888,1,1,1,proton channel activity,MF,692,175,141,245,156,96,157,593,386,102,143,75,3929,200.5987164,0.86326496,0.23687422,3.644402327,0.000268014,0.045253115,CvsHigh
209,plut2.m8.21703,GO:0048626,0.007992687,1,1,1,myoblast fate specification,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
210,plut2.m8.21703,GO:0048626,0.007992687,1,1,1,myoblast fate specification,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
211,plut2.m8.21703,GO:0035169,0.007992687,1,1,1,lymph gland plasmatocyte differentiation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
212,plut2.m8.21703,GO:0035169,0.007992687,1,1,1,lymph gland plasmatocyte differentiation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
213,plut2.m8.21703,GO:0035170,0.007992687,1,1,1,lymph gland crystal cell differentiation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
214,plut2.m8.21703,GO:0035170,0.007992687,1,1,1,lymph gland crystal cell differentiation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
215,plut2.m8.21703,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
216,plut2.m8.21703,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
217,plut2.m8.21703,GO:2001107,0.017354604,0.999924541,1,2,negative regulation of Rho guanyl-nucleotide exchange factor activity,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
218,plut2.m8.21703,GO:2001107,0.017354604,0.999924541,1,2,negative regulation of Rho guanyl-nucleotide exchange factor activity,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
219,plut2.m8.21703,GO:0007500,0.015291358,0.999941478,1,2,mesodermal cell fate determination,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
220,plut2.m8.21703,GO:0007500,0.015291358,0.999941478,1,2,mesodermal cell fate determination,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
221,plut2.m8.21703,GO:1903977,0.007992687,1,1,1,positive regulation of glial cell migration,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
222,plut2.m8.21703,GO:1903977,0.007992687,1,1,1,positive regulation of glial cell migration,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
223,plut2.m8.21703,GO:0010002,0.04795123,0.999068222,1,5,cardioblast differentiation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
224,plut2.m8.21703,GO:0010002,0.04795123,0.999068222,1,5,cardioblast differentiation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
225,plut2.m8.21703,GO:0007506,0.007992687,1,1,1,gonadal mesoderm development,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
226,plut2.m8.21703,GO:0007506,0.007992687,1,1,1,gonadal mesoderm development,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
227,plut2.m8.21703,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
228,plut2.m8.21703,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
229,plut2.m8.21703,GO:0098975,0.007992687,1,1,1,postsynapse of neuromuscular junction,CC,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
230,plut2.m8.21703,GO:0098975,0.007992687,1,1,1,postsynapse of neuromuscular junction,CC,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
231,plut2.m8.21703,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
232,plut2.m8.21703,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
233,plut2.m8.21703,GO:0007523,0.007992687,1,1,1,larval visceral muscle development,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
234,plut2.m8.21703,GO:0007523,0.007992687,1,1,1,larval visceral muscle development,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
235,plut2.m8.21703,GO:0007525,0.039752237,0.9993618,1,5,somatic muscle development,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
236,plut2.m8.21703,GO:0007525,0.039752237,0.9993618,1,5,somatic muscle development,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
237,plut2.m8.21703,GO:0004713,0.002387017,0.999579723,6,145,protein tyrosine kinase activity,MF,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
238,plut2.m8.21703,GO:0004713,0.002387017,0.999579723,6,145,protein tyrosine kinase activity,MF,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
239,plut2.m8.21703,GO:0008360,0.023132412,0.998365526,2,24,regulation of cell shape,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
240,plut2.m8.21703,GO:0008360,0.023132412,0.998365526,2,24,regulation of cell shape,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
241,plut2.m8.21703,GO:0110122,0.007992687,1,1,1,myotube cell migration,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
242,plut2.m8.21703,GO:0110122,0.007992687,1,1,1,myotube cell migration,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
243,plut2.m8.21703,GO:0042065,0.007992687,1,1,1,glial cell growth,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
244,plut2.m8.21703,GO:0042065,0.007992687,1,1,1,glial cell growth,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
245,plut2.m8.21703,GO:0007509,0.016047825,0.99993552,1,2,mesoderm migration involved in gastrulation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
246,plut2.m8.21703,GO:0007509,0.016047825,0.99993552,1,2,mesoderm migration involved in gastrulation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
247,plut2.m8.21703,GO:0045792,0.046516114,0.995096762,2,38,negative regulation of cell size,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
248,plut2.m8.21703,GO:0045792,0.046516114,0.995096762,2,38,negative regulation of cell size,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
249,plut2.m8.21703,GO:0061320,0.007992687,1,1,1,pericardial nephrocyte differentiation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
250,plut2.m8.21703,GO:0061320,0.007992687,1,1,1,pericardial nephrocyte differentiation,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
251,plut2.m8.21703,GO:0007493,0.015483379,0.999939993,1,2,endodermal cell fate determination,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,-1.971244026,0.527141312,-3.739498273,0.000184388,0.029822319,CvsMid
252,plut2.m8.21703,GO:0007493,0.015483379,0.999939993,1,2,endodermal cell fate determination,BP,44,7,22,12,159,15,10,66,22,17,87,9,2799,36.05119957,2.383461607,0.548585069,4.344743856,1.39E-05,0.022625602,MidvsHigh
253,plut2.m8.21905,GO:0030027,0.023672016,0.996676695,3,58,lamellipodium,CC,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
254,plut2.m8.21905,GO:0004673,0.011997458,1,1,1,protein histidine kinase activity,MF,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
255,plut2.m8.21905,GO:0018106,0.011997458,1,1,1,peptidyl-histidine phosphorylation,BP,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
256,plut2.m8.21905,GO:0045618,0.041588768,0.999344162,1,4,positive regulation of keratinocyte differentiation,BP,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
257,plut2.m8.21905,GO:0019215,0.020392554,0.999895648,1,2,intermediate filament binding,MF,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
258,plut2.m8.21905,GO:0006241,0.037046843,0.999537831,1,3,CTP biosynthetic process,BP,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
259,plut2.m8.21905,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
260,plut2.m8.21905,GO:0006228,0.01978946,0.99990176,1,2,UTP biosynthetic process,BP,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
261,plut2.m8.21905,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
262,plut2.m8.21905,GO:0045944,0.044572701,0.983625155,7,327,positive regulation of transcription by RNA polymerase II,BP,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
263,plut2.m8.21905,GO:0007229,0.015215116,0.999153664,2,19,integrin-mediated signaling pathway,BP,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
264,plut2.m8.21905,GO:0006183,0.03563585,0.99951971,1,4,GTP biosynthetic process,BP,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
265,plut2.m8.21905,GO:0002762,0.020001549,0.999899632,1,2,negative regulation of myeloid leukocyte differentiation,BP,161,33,14,35,29,42,39,107,87,20,9,10,1180,36.59476946,1.362511909,0.289448816,4.707263723,2.51E-06,0.000989128,CvsMid
266,plut2.m8.22300,GO:0007596,0.019408847,0.998767099,2,20,blood coagulation,BP,42,55,13,0,74,61,40,37,27,34,22,12,957,33.43858113,-2.091451365,0.453911055,-4.60762377,4.07E-06,0.001564529,CvsHigh
267,plut2.m8.22300,GO:0007599,0.028161525,0.997778667,2,26,hemostasis,BP,42,55,13,0,74,61,40,37,27,34,22,12,957,33.43858113,-2.091451365,0.453911055,-4.60762377,4.07E-06,0.001564529,CvsHigh
268,plut2.m8.22300,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,42,55,13,0,74,61,40,37,27,34,22,12,957,33.43858113,-2.091451365,0.453911055,-4.60762377,4.07E-06,0.001564529,CvsHigh
269,plut2.m8.22577,GO:1901564,0.02682594,0.996036605,3,65,organonitrogen compound metabolic process,BP,33,52,34,11,47,24,39,54,23,28,40,22,2361,35.17421842,-1.29524329,0.332647454,-3.893741786,9.87E-05,0.019956248,CvsHigh
270,plut2.m8.22577,GO:1901564,0.02682594,0.996036605,3,65,organonitrogen compound metabolic process,BP,33,52,34,11,47,24,39,54,23,28,40,22,2361,35.17421842,-1.536936467,0.333757733,-4.604946384,4.13E-06,0.001440721,CvsMid
271,plut2.m8.22609,GO:0004307,0.027969207,0.999802938,1,2,ethanolaminephosphotransferase activity,MF,814,183,138,296,191,82,168,637,499,120,134,80,5791,221.8923154,1.040760176,0.24067059,4.324417771,1.53E-05,0.004795612,CvsHigh
272,plut2.m8.22609,GO:0016780,0.022510688,0.999830492,1,3,"phosphotransferase activity, for other substituted phosphate groups",MF,814,183,138,296,191,82,168,637,499,120,134,80,5791,221.8923154,1.040760176,0.24067059,4.324417771,1.53E-05,0.004795612,CvsHigh
273,plut2.m8.22609,GO:0006646,0.000504796,0.999996908,2,4,phosphatidylethanolamine biosynthetic process,BP,814,183,138,296,191,82,168,637,499,120,134,80,5791,221.8923154,1.040760176,0.24067059,4.324417771,1.53E-05,0.004795612,CvsHigh
274,plut2.m8.23195,GO:2000146,0.029620326,0.999705558,1,3,negative regulation of cell motility,BP,57,48,22,15,34,37,28,47,22,37,13,18,1510,30.87141063,-1.193636839,0.320375084,-3.725748035,0.000194737,0.035878906,CvsHigh
275,plut2.m8.23195,GO:0005912,0.037060493,0.996578409,2,31,adherens junction,CC,57,48,22,15,34,37,28,47,22,37,13,18,1510,30.87141063,-1.193636839,0.320375084,-3.725748035,0.000194737,0.035878906,CvsHigh
276,plut2.m8.23282,GO:2000809,0.007990254,1,1,1,positive regulation of synaptic vesicle clustering,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
277,plut2.m8.23282,GO:2000809,0.007990254,1,1,1,positive regulation of synaptic vesicle clustering,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
278,plut2.m8.23282,GO:1990646,0.015964799,0.999936188,1,2,cellular response to prolactin,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
279,plut2.m8.23282,GO:1990646,0.015964799,0.999936188,1,2,cellular response to prolactin,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
280,plut2.m8.23282,GO:1900452,0.015973913,0.999936115,1,2,regulation of long-term synaptic depression,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
281,plut2.m8.23282,GO:1900452,0.015973913,0.999936115,1,2,regulation of long-term synaptic depression,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
282,plut2.m8.23282,GO:1900118,0.007990254,1,1,1,negative regulation of execution phase of apoptosis,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
283,plut2.m8.23282,GO:1900118,0.007990254,1,1,1,negative regulation of execution phase of apoptosis,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
284,plut2.m8.23282,GO:0046902,0.024167594,0.999853154,1,2,regulation of mitochondrial membrane permeability,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
285,plut2.m8.23282,GO:0046902,0.024167594,0.999853154,1,2,regulation of mitochondrial membrane permeability,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
286,plut2.m8.23282,GO:1904579,0.01751754,0.999923111,1,2,cellular response to thapsigargin,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
287,plut2.m8.23282,GO:1904579,0.01751754,0.999923111,1,2,cellular response to thapsigargin,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
288,plut2.m8.23282,GO:2001171,0.035017046,0.999587473,1,3,positive regulation of ATP biosynthetic process,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
289,plut2.m8.23282,GO:2001171,0.035017046,0.999587473,1,3,positive regulation of ATP biosynthetic process,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
290,plut2.m8.23282,GO:2000302,0.007990254,1,1,1,positive regulation of synaptic vesicle exocytosis,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
291,plut2.m8.23282,GO:2000302,0.007990254,1,1,1,positive regulation of synaptic vesicle exocytosis,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
292,plut2.m8.23282,GO:1902230,0.02042233,0.999895342,1,2,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
293,plut2.m8.23282,GO:1902230,0.02042233,0.999895342,1,2,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
294,plut2.m8.23282,GO:0097136,0.007990254,1,1,1,Bcl-2 family protein complex,CC,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
295,plut2.m8.23282,GO:0097136,0.007990254,1,1,1,Bcl-2 family protein complex,CC,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
296,plut2.m8.23282,GO:0042542,0.024208775,0.998234843,2,27,response to hydrogen peroxide,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
297,plut2.m8.23282,GO:0042542,0.024208775,0.998234843,2,27,response to hydrogen peroxide,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
298,plut2.m8.23282,GO:0071312,0.016381358,0.9999328,1,2,cellular response to alkaloid,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
299,plut2.m8.23282,GO:0071312,0.016381358,0.9999328,1,2,cellular response to alkaloid,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
300,plut2.m8.23282,GO:0019050,0.007990254,1,1,1,suppression by virus of host apoptotic process,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
301,plut2.m8.23282,GO:0019050,0.007990254,1,1,1,suppression by virus of host apoptotic process,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
302,plut2.m8.23282,GO:2000811,0.04618892,0.999100565,1,6,negative regulation of anoikis,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
303,plut2.m8.23282,GO:2000811,0.04618892,0.999100565,1,6,negative regulation of anoikis,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
304,plut2.m8.23282,GO:0097371,0.027629386,0.999744043,1,3,MDM2/MDM4 family protein binding,MF,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
305,plut2.m8.23282,GO:0097371,0.027629386,0.999744043,1,3,MDM2/MDM4 family protein binding,MF,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
306,plut2.m8.23282,GO:1905218,0.007990254,1,1,1,cellular response to astaxanthin,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
307,plut2.m8.23282,GO:1905218,0.007990254,1,1,1,cellular response to astaxanthin,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
308,plut2.m8.23282,GO:1903077,0.048940543,0.998989083,1,6,negative regulation of protein localization to plasma membrane,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
309,plut2.m8.23282,GO:1903077,0.048940543,0.998989083,1,6,negative regulation of protein localization to plasma membrane,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
310,plut2.m8.23282,GO:0036018,0.016046901,0.999935527,1,2,cellular response to erythropoietin,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
311,plut2.m8.23282,GO:0036018,0.016046901,0.999935527,1,2,cellular response to erythropoietin,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
312,plut2.m8.23282,GO:0036466,0.007990254,1,1,1,synaptic vesicle recycling via endosome,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
313,plut2.m8.23282,GO:0036466,0.007990254,1,1,1,synaptic vesicle recycling via endosome,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
314,plut2.m8.23282,GO:0051881,0.00586522,0.999811629,2,12,regulation of mitochondrial membrane potential,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
315,plut2.m8.23282,GO:0051881,0.00586522,0.999811629,2,12,regulation of mitochondrial membrane potential,BP,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
316,plut2.m8.23282,GO:0051434,0.007990254,1,1,1,BH3 domain binding,MF,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.417338797,0.5385193,4.488861954,7.16E-06,0.018590007,MidvsHigh
317,plut2.m8.23282,GO:0051434,0.007990254,1,1,1,BH3 domain binding,MF,122,10,18,93,202,13,17,126,84,11,59,16,2803,54.43858555,2.275753562,0.534225845,4.259909144,2.05E-05,0.005611244,CvsHigh
318,plut2.m8.23335,GO:0007596,0.019408847,0.998767099,2,20,blood coagulation,BP,390,95,68,113,94,56,79,371,206,59,62,34,2865,105.4858176,0.843900374,0.219552136,3.843735654,0.000121176,0.024180026,CvsHigh
319,plut2.m8.23335,GO:0007599,0.028161525,0.997778667,2,26,hemostasis,BP,390,95,68,113,94,56,79,371,206,59,62,34,2865,105.4858176,0.843900374,0.219552136,3.843735654,0.000121176,0.024180026,CvsHigh
320,plut2.m8.23335,GO:0046130,0.015094826,0.999942979,1,2,purine ribonucleoside catabolic process,BP,390,95,68,113,94,56,79,371,206,59,62,34,2865,105.4858176,0.843900374,0.219552136,3.843735654,0.000121176,0.024180026,CvsHigh
321,plut2.m8.23335,GO:0047710,0.007951236,1,1,1,bis(5'-adenosyl)-triphosphatase activity,MF,390,95,68,113,94,56,79,371,206,59,62,34,2865,105.4858176,0.843900374,0.219552136,3.843735654,0.000121176,0.024180026,CvsHigh
322,plut2.m8.24267,GO:0003674,0.021909676,0.993808785,6,219,molecular_function,MF,62,45,10,5,16,90,51,16,27,14,12,12,693,28.82828394,-2.076437762,0.474395412,-4.377019066,1.20E-05,0.004104981,CvsHigh
323,plut2.m8.24269,GO:0015431,0.019675104,0.998724302,2,24,ATPase-coupled glutathione S-conjugate transmembrane transporter activity,MF,182,72,16,10,23,195,105,109,78,38,26,19,1680,62.87352873,-1.974312514,0.465264061,-4.243423642,2.20E-05,0.028575763,MidvsHigh
324,plut2.m8.24269,GO:0042887,0.032596491,0.999598668,1,4,amide transmembrane transporter activity,MF,182,72,16,10,23,195,105,109,78,38,26,19,1680,62.87352873,-1.974312514,0.465264061,-4.243423642,2.20E-05,0.028575763,MidvsHigh
325,plut2.m8.24269,GO:0140115,0.019975787,0.99869809,2,23,export across plasma membrane,BP,182,72,16,10,23,195,105,109,78,38,26,19,1680,62.87352873,-1.974312514,0.465264061,-4.243423642,2.20E-05,0.028575763,MidvsHigh
326,plut2.m8.24269,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,182,72,16,10,23,195,105,109,78,38,26,19,1680,62.87352873,-1.974312514,0.465264061,-4.243423642,2.20E-05,0.028575763,MidvsHigh
327,plut2.m8.24269,GO:0015432,0.014573929,0.999204069,2,20,ATPase-coupled bile acid transmembrane transporter activity,MF,182,72,16,10,23,195,105,109,78,38,26,19,1680,62.87352873,-1.974312514,0.465264061,-4.243423642,2.20E-05,0.028575763,MidvsHigh
328,plut2.m8.24269,GO:0071716,0.018371988,0.998854493,2,23,leukotriene transport,BP,182,72,16,10,23,195,105,109,78,38,26,19,1680,62.87352873,-1.974312514,0.465264061,-4.243423642,2.20E-05,0.028575763,MidvsHigh
329,plut2.m8.24269,GO:0042908,0.016151185,0.999065346,2,21,xenobiotic transport,BP,182,72,16,10,23,195,105,109,78,38,26,19,1680,62.87352873,-1.974312514,0.465264061,-4.243423642,2.20E-05,0.028575763,MidvsHigh
330,plut2.m8.24633,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,210,2250,1107,58,2882,1299,2172,109,166,985,2992,936,1626,1485.67812,-4.637749063,0.280036534,-16.5612286,1.33E-61,2.04E-57,CvsHigh
331,plut2.m8.24633,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,210,2250,1107,58,2882,1299,2172,109,166,985,2992,936,1626,1485.67812,-5.053257598,0.280013337,-18.046489,8.41E-73,1.29E-68,CvsMid
332,plut2.m8.2498,GO:0005112,0.001256689,0.999942694,3,21,Notch binding,MF,16,18,10,5,22,8,14,25,9,12,27,11,2697,15.16856464,-1.633270502,0.429840492,-3.799712993,0.000144864,0.024459689,CvsMid
333,plut2.m8.24994,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,26,9,10,3,48,11,17,12,14,10,41,6,522,16.7962161,-2.155101955,0.463008769,-4.654559701,3.25E-06,0.001160142,CvsMid
334,plut2.m8.24994,GO:0060218,0.008446077,0.999662603,2,15,hematopoietic stem cell differentiation,BP,26,9,10,3,48,11,17,12,14,10,41,6,522,16.7962161,-2.155101955,0.463008769,-4.654559701,3.25E-06,0.001160142,CvsMid
335,plut2.m8.24994,GO:0003700,0.045552954,0.988855755,4,129,DNA-binding transcription factor activity,MF,26,9,10,3,48,11,17,12,14,10,41,6,522,16.7962161,-2.155101955,0.463008769,-4.654559701,3.25E-06,0.001160142,CvsMid
336,plut2.m8.24994,GO:0045944,0.044572701,0.983625155,7,327,positive regulation of transcription by RNA polymerase II,BP,26,9,10,3,48,11,17,12,14,10,41,6,522,16.7962161,-2.155101955,0.463008769,-4.654559701,3.25E-06,0.001160142,CvsMid
337,plut2.m8.25740,GO:0045002,0.026771311,0.999819568,1,2,double-strand break repair via single-strand annealing,BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-2.119604544,0.435335748,-4.868896141,1.12E-06,0.00059459,CvsHigh
338,plut2.m8.25740,GO:0045002,0.026771311,0.999819568,1,2,double-strand break repair via single-strand annealing,BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-1.94377471,0.436839431,-4.449631998,8.60E-06,0.002447518,CvsMid
339,plut2.m8.25740,GO:0005760,0.033925949,0.999612974,1,3,gamma DNA polymerase complex,CC,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-2.119604544,0.435335748,-4.868896141,1.12E-06,0.00059459,CvsHigh
340,plut2.m8.25740,GO:0005760,0.033925949,0.999612974,1,3,gamma DNA polymerase complex,CC,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-1.94377471,0.436839431,-4.449631998,8.60E-06,0.002447518,CvsMid
341,plut2.m8.25740,GO:0043137,0.033721631,0.999617657,1,3,"DNA replication, removal of RNA primer",BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-2.119604544,0.435335748,-4.868896141,1.12E-06,0.00059459,CvsHigh
342,plut2.m8.25740,GO:0043137,0.033721631,0.999617657,1,3,"DNA replication, removal of RNA primer",BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-1.94377471,0.436839431,-4.449631998,8.60E-06,0.002447518,CvsMid
343,plut2.m8.25740,GO:0043504,0.001977759,0.999967691,2,7,mitochondrial DNA repair,BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-2.119604544,0.435335748,-4.868896141,1.12E-06,0.00059459,CvsHigh
344,plut2.m8.25740,GO:0043504,0.001977759,0.999967691,2,7,mitochondrial DNA repair,BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-1.94377471,0.436839431,-4.449631998,8.60E-06,0.002447518,CvsMid
345,plut2.m8.25740,GO:0006264,0.002970756,0.999936181,2,9,mitochondrial DNA replication,BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-2.119604544,0.435335748,-4.868896141,1.12E-06,0.00059459,CvsHigh
346,plut2.m8.25740,GO:0006264,0.002970756,0.999936181,2,9,mitochondrial DNA replication,BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-1.94377471,0.436839431,-4.449631998,8.60E-06,0.002447518,CvsMid
347,plut2.m8.25740,GO:0016890,0.046150891,0.999190788,1,4,"site-specific endodeoxyribonuclease activity, specific for altered base",MF,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-2.119604544,0.435335748,-4.868896141,1.12E-06,0.00059459,CvsHigh
348,plut2.m8.25740,GO:0016890,0.046150891,0.999190788,1,4,"site-specific endodeoxyribonuclease activity, specific for altered base",MF,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-1.94377471,0.436839431,-4.449631998,8.60E-06,0.002447518,CvsMid
349,plut2.m8.25740,GO:1902990,0.026771311,0.999819568,1,2,mitotic telomere maintenance via semi-conservative replication,BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-2.119604544,0.435335748,-4.868896141,1.12E-06,0.00059459,CvsHigh
350,plut2.m8.25740,GO:1902990,0.026771311,0.999819568,1,2,mitotic telomere maintenance via semi-conservative replication,BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-1.94377471,0.436839431,-4.449631998,8.60E-06,0.002447518,CvsMid
351,plut2.m8.25740,GO:0043139,0.00322257,0.999929818,2,8,5'-3' DNA helicase activity,MF,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-2.119604544,0.435335748,-4.868896141,1.12E-06,0.00059459,CvsHigh
352,plut2.m8.25740,GO:0043139,0.00322257,0.999929818,2,8,5'-3' DNA helicase activity,MF,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-1.94377471,0.436839431,-4.449631998,8.60E-06,0.002447518,CvsMid
353,plut2.m8.25740,GO:0033567,0.034008729,0.999611068,1,3,"DNA replication, Okazaki fragment processing",BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-2.119604544,0.435335748,-4.868896141,1.12E-06,0.00059459,CvsHigh
354,plut2.m8.25740,GO:0033567,0.034008729,0.999611068,1,3,"DNA replication, Okazaki fragment processing",BP,85,106,146,35,171,316,113,170,43,157,179,49,1298,142.4341656,-1.94377471,0.436839431,-4.449631998,8.60E-06,0.002447518,CvsMid
355,plut2.m8.25928,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,429,87,71,159,66,30,70,341,244,43,53,22,4074,102.3827545,1.245864159,0.326739964,3.813014306,0.000137282,0.023700454,CvsMid
356,plut2.m8.25928,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,429,87,71,159,66,30,70,341,244,43,53,22,4074,102.3827545,1.384753419,0.324741015,4.26417777,2.01E-05,0.005605143,CvsHigh
357,plut2.m8.26038,GO:0036126,0.034429864,0.996950332,2,30,sperm flagellum,CC,48,40,29,18,39,23,34,36,21,27,33,19,3879,31.41481368,-1.242208129,0.298003295,-4.168437564,3.07E-05,0.006832556,CvsMid
358,plut2.m8.26038,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,48,40,29,18,39,23,34,36,21,27,33,19,3879,31.41481368,-1.242208129,0.298003295,-4.168437564,3.07E-05,0.006832556,CvsMid
359,plut2.m8.26404,GO:1990935,0.034946034,0.999691255,1,2,splicing factor binding,MF,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.163892784,0.772099737,-4.097777309,4.17E-05,0.010173491,CvsHigh
360,plut2.m8.26404,GO:1990935,0.034946034,0.999691255,1,2,splicing factor binding,MF,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.013390926,0.773137527,-3.897613063,9.71E-05,0.017983616,CvsMid
361,plut2.m8.26404,GO:0071013,0.034826319,0.996901479,2,29,catalytic step 2 spliceosome,CC,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.163892784,0.772099737,-4.097777309,4.17E-05,0.010173491,CvsHigh
362,plut2.m8.26404,GO:0071013,0.034826319,0.996901479,2,29,catalytic step 2 spliceosome,CC,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.013390926,0.773137527,-3.897613063,9.71E-05,0.017983616,CvsMid
363,plut2.m8.26404,GO:0034693,0.030198885,0.999770003,1,2,U11/U12 snRNP,CC,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.163892784,0.772099737,-4.097777309,4.17E-05,0.010173491,CvsHigh
364,plut2.m8.26404,GO:0034693,0.030198885,0.999770003,1,2,U11/U12 snRNP,CC,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.013390926,0.773137527,-3.897613063,9.71E-05,0.017983616,CvsMid
365,plut2.m8.26404,GO:0000245,0.004146037,0.999892024,2,10,spliceosomal complex assembly,BP,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.163892784,0.772099737,-4.097777309,4.17E-05,0.010173491,CvsHigh
366,plut2.m8.26404,GO:0000245,0.004146037,0.999892024,2,10,spliceosomal complex assembly,BP,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.013390926,0.773137527,-3.897613063,9.71E-05,0.017983616,CvsMid
367,plut2.m8.26404,GO:0071005,0.037310701,0.996554312,2,29,U2-type precatalytic spliceosome,CC,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.163892784,0.772099737,-4.097777309,4.17E-05,0.010173491,CvsHigh
368,plut2.m8.26404,GO:0071005,0.037310701,0.996554312,2,29,U2-type precatalytic spliceosome,CC,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.013390926,0.773137527,-3.897613063,9.71E-05,0.017983616,CvsMid
369,plut2.m8.26404,GO:0005689,0.00691923,0.999757953,2,12,U12-type spliceosomal complex,CC,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.163892784,0.772099737,-4.097777309,4.17E-05,0.010173491,CvsHigh
370,plut2.m8.26404,GO:0005689,0.00691923,0.999757953,2,12,U12-type spliceosomal complex,CC,41,47,134,22,19,170,226,11,35,106,104,92,309,105.8292133,-3.013390926,0.773137527,-3.897613063,9.71E-05,0.017983616,CvsMid
371,plut2.m8.28609,GO:1901564,0.02682594,0.996036605,3,65,organonitrogen compound metabolic process,BP,272,68,26,55,71,35,54,177,154,49,32,17,1294,63.46488893,0.912398144,0.237491149,3.841819566,0.000122126,0.0215433,CvsMid
372,plut2.m8.28828,GO:0010820,0.038323937,0.999443875,1,4,positive regulation of T cell chemotaxis,BP,51,40,33,16,44,32,44,44,23,24,33,16,2718,33.41230388,-1.196145046,0.282139068,-4.239558371,2.24E-05,0.005462134,CvsMid
373,plut2.m8.28828,GO:0010820,0.038323937,0.999443875,1,4,positive regulation of T cell chemotaxis,BP,51,40,33,16,44,32,44,44,23,24,33,16,2718,33.41230388,-1.127810969,0.277727671,-4.060852002,4.89E-05,0.011382662,CvsHigh
374,plut2.m8.28828,GO:0051089,0.029110426,0.999715674,1,3,constitutive protein ectodomain proteolysis,BP,51,40,33,16,44,32,44,44,23,24,33,16,2718,33.41230388,-1.196145046,0.282139068,-4.239558371,2.24E-05,0.005462134,CvsMid
375,plut2.m8.28828,GO:0051089,0.029110426,0.999715674,1,3,constitutive protein ectodomain proteolysis,BP,51,40,33,16,44,32,44,44,23,24,33,16,2718,33.41230388,-1.127810969,0.277727671,-4.060852002,4.89E-05,0.011382662,CvsHigh
376,plut2.m8.28828,GO:1902945,0.046233621,0.999134398,1,5,metalloendopeptidase activity involved in amyloid precursor protein catabolic process,MF,51,40,33,16,44,32,44,44,23,24,33,16,2718,33.41230388,-1.196145046,0.282139068,-4.239558371,2.24E-05,0.005462134,CvsMid
377,plut2.m8.28828,GO:1902945,0.046233621,0.999134398,1,5,metalloendopeptidase activity involved in amyloid precursor protein catabolic process,MF,51,40,33,16,44,32,44,44,23,24,33,16,2718,33.41230388,-1.127810969,0.277727671,-4.060852002,4.89E-05,0.011382662,CvsHigh
378,plut2.m8.28828,GO:0042117,0.036994457,0.999482087,1,4,monocyte activation,BP,51,40,33,16,44,32,44,44,23,24,33,16,2718,33.41230388,-1.196145046,0.282139068,-4.239558371,2.24E-05,0.005462134,CvsMid
379,plut2.m8.28828,GO:0042117,0.036994457,0.999482087,1,4,monocyte activation,BP,51,40,33,16,44,32,44,44,23,24,33,16,2718,33.41230388,-1.127810969,0.277727671,-4.060852002,4.89E-05,0.011382662,CvsHigh
380,plut2.m8.29528,GO:0043467,0.039328628,0.99941408,1,4,regulation of generation of precursor metabolites and energy,BP,10,18,27,2,32,9,25,20,7,21,19,8,4434,18.10105116,-2.443511202,0.483987249,-5.048709873,4.45E-07,0.000213575,CvsMid
381,plut2.m8.29528,GO:0043467,0.039328628,0.99941408,1,4,regulation of generation of precursor metabolites and energy,BP,10,18,27,2,32,9,25,20,7,21,19,8,4434,18.10105116,-2.021544717,0.486057242,-4.159067171,3.20E-05,0.008183141,CvsHigh
382,plut2.m8.29610,GO:0015226,0.037928301,0.999455391,1,4,carnitine transmembrane transporter activity,MF,99,51,39,20,243,49,67,57,35,60,114,29,1338,70.5692607,-2.127020095,0.362200497,-5.872493591,4.29E-09,3.66E-06,CvsMid
383,plut2.m8.29610,GO:1901564,0.02682594,0.996036605,3,65,organonitrogen compound metabolic process,BP,99,51,39,20,243,49,67,57,35,60,114,29,1338,70.5692607,-2.127020095,0.362200497,-5.872493591,4.29E-09,3.66E-06,CvsMid
384,plut2.m8.29610,GO:1902603,0.0297436,0.999703085,1,3,carnitine transmembrane transport,BP,99,51,39,20,243,49,67,57,35,60,114,29,1338,70.5692607,-2.127020095,0.362200497,-5.872493591,4.29E-09,3.66E-06,CvsMid
385,plut2.m8.30338,GO:0006477,0.022136078,0.999836115,1,3,protein sulfation,BP,12,17,8,0,20,14,19,15,7,15,10,8,2074,12.4936794,-2.088204314,0.441064997,-4.734459388,2.20E-06,0.000964218,CvsHigh
386,plut2.m8.30338,GO:0006477,0.022136078,0.999836115,1,3,protein sulfation,BP,12,17,8,0,20,14,19,15,7,15,10,8,2074,12.4936794,-1.771542318,0.459164656,-3.858185284,0.000114232,0.020409015,CvsMid
387,plut2.m8.30338,GO:0008467,0.014890121,0.99994452,1,2,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,12,17,8,0,20,14,19,15,7,15,10,8,2074,12.4936794,-2.088204314,0.441064997,-4.734459388,2.20E-06,0.000964218,CvsHigh
388,plut2.m8.30338,GO:0008467,0.014890121,0.99994452,1,2,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,12,17,8,0,20,14,19,15,7,15,10,8,2074,12.4936794,-1.771542318,0.459164656,-3.858185284,0.000114232,0.020409015,CvsMid
389,plut2.m8.30846,GO:0040011,0.012369884,0.99864808,3,47,locomotion,BP,15,27,7,0,25,33,23,16,9,15,14,11,964,16.92418547,-2.44618056,0.421453028,-5.804159415,6.47E-09,5.52E-06,CvsHigh
390,plut2.m8.30846,GO:0040011,0.012369884,0.99864808,3,47,locomotion,BP,15,27,7,0,25,33,23,16,9,15,14,11,964,16.92418547,-1.853643168,0.442280925,-4.191099057,2.78E-05,0.006366302,CvsMid
391,plut2.m8.31278,GO:0031400,0.038378143,0.999442288,1,4,negative regulation of protein modification process,BP,49,22,20,3,25,19,41,13,21,44,18,21,899,25.88950561,-1.838326569,0.456326991,-4.028529114,5.61E-05,0.012682206,CvsHigh
392,plut2.m8.31278,GO:1905259,0.014658604,1,1,1,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,49,22,20,3,25,19,41,13,21,44,18,21,899,25.88950561,-1.838326569,0.456326991,-4.028529114,5.61E-05,0.012682206,CvsHigh
393,plut2.m8.31278,GO:1903748,0.014658604,1,1,1,negative regulation of establishment of protein localization to mitochondrion,BP,49,22,20,3,25,19,41,13,21,44,18,21,899,25.88950561,-1.838326569,0.456326991,-4.028529114,5.61E-05,0.012682206,CvsHigh
394,plut2.m8.31557,GO:0005575,0.03213374,0.991382616,5,178,cellular_component,CC,76,36,24,17,48,70,51,30,42,29,39,23,2408,39.98259126,-1.266969454,0.303784998,-4.170612313,3.04E-05,0.007911212,CvsHigh
395,plut2.m8.31557,GO:0003674,0.021909676,0.993808785,6,219,molecular_function,MF,76,36,24,17,48,70,51,30,42,29,39,23,2408,39.98259126,-1.266969454,0.303784998,-4.170612313,3.04E-05,0.007911212,CvsHigh
396,plut2.m8.31969,GO:0030686,0.043709847,0.999274894,1,4,90S preribosome,CC,38,76,30,0,106,101,48,34,23,50,35,24,705,49.32600321,-2.769980677,0.409078902,-6.77126262,1.28E-11,1.51E-08,CvsHigh
397,plut2.m8.31969,GO:0030686,0.043709847,0.999274894,1,4,90S preribosome,CC,38,76,30,0,106,101,48,34,23,50,35,24,705,49.32600321,-2.360866237,0.415294489,-5.684800308,1.31E-08,1.01E-05,CvsMid
398,plut2.m8.32388,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
399,plut2.m8.32388,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
400,plut2.m8.32388,GO:0043408,0.022514127,0.998441324,2,22,regulation of MAPK cascade,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
401,plut2.m8.32388,GO:0043408,0.022514127,0.998441324,2,22,regulation of MAPK cascade,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
402,plut2.m8.32388,GO:0007169,0.044255717,0.995481018,2,34,transmembrane receptor protein tyrosine kinase signaling pathway,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
403,plut2.m8.32388,GO:0007169,0.044255717,0.995481018,2,34,transmembrane receptor protein tyrosine kinase signaling pathway,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
404,plut2.m8.32388,GO:0021545,0.043940851,0.999267136,1,4,cranial nerve development,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
405,plut2.m8.32388,GO:0021545,0.043940851,0.999267136,1,4,cranial nerve development,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
406,plut2.m8.32388,GO:0060996,0.003081911,0.999934399,2,8,dendritic spine development,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
407,plut2.m8.32388,GO:0060996,0.003081911,0.999934399,2,8,dendritic spine development,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
408,plut2.m8.32388,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
409,plut2.m8.32388,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
410,plut2.m8.32388,GO:0005003,0.004406729,0.999887287,2,8,ephrin receptor activity,MF,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
411,plut2.m8.32388,GO:0005003,0.004406729,0.999887287,2,8,ephrin receptor activity,MF,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
412,plut2.m8.32388,GO:0004713,0.002387017,0.999579723,6,145,protein tyrosine kinase activity,MF,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
413,plut2.m8.32388,GO:0004713,0.002387017,0.999579723,6,145,protein tyrosine kinase activity,MF,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
414,plut2.m8.32388,GO:0008037,0.022047981,0.999877915,1,2,cell recognition,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
415,plut2.m8.32388,GO:0008037,0.022047981,0.999877915,1,2,cell recognition,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
416,plut2.m8.32388,GO:1901888,0.040831056,0.999368049,1,4,regulation of cell junction assembly,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
417,plut2.m8.32388,GO:1901888,0.040831056,0.999368049,1,4,regulation of cell junction assembly,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
418,plut2.m8.32388,GO:0016477,0.002553513,0.999635491,5,96,cell migration,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
419,plut2.m8.32388,GO:0016477,0.002553513,0.999635491,5,96,cell migration,BP,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
420,plut2.m8.32388,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.23335001,0.267475121,4.611083105,4.01E-06,0.001564529,CvsHigh
421,plut2.m8.32388,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,149,24,8,49,22,22,26,111,98,13,18,10,873,33.64590955,1.583034924,0.290423261,5.450785579,5.01E-08,3.35E-05,CvsMid
422,plut2.m8.32471,GO:0004713,0.002387017,0.999579723,6,145,protein tyrosine kinase activity,MF,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-2.015044234,0.424516825,-4.74667696,2.07E-06,0.000836122,CvsMid
423,plut2.m8.32471,GO:0004713,0.002387017,0.999579723,6,145,protein tyrosine kinase activity,MF,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-1.991283662,0.417301774,-4.771807325,1.83E-06,0.000877092,CvsHigh
424,plut2.m8.32471,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-2.015044234,0.424516825,-4.74667696,2.07E-06,0.000836122,CvsMid
425,plut2.m8.32471,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-1.991283662,0.417301774,-4.771807325,1.83E-06,0.000877092,CvsHigh
426,plut2.m8.32471,GO:0009723,0.003025668,0.999934389,2,9,response to ethylene,BP,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-2.015044234,0.424516825,-4.74667696,2.07E-06,0.000836122,CvsMid
427,plut2.m8.32471,GO:0009723,0.003025668,0.999934389,2,9,response to ethylene,BP,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-1.991283662,0.417301774,-4.771807325,1.83E-06,0.000877092,CvsHigh
428,plut2.m8.32471,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-2.015044234,0.424516825,-4.74667696,2.07E-06,0.000836122,CvsMid
429,plut2.m8.32471,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-1.991283662,0.417301774,-4.771807325,1.83E-06,0.000877092,CvsHigh
430,plut2.m8.32471,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-2.015044234,0.424516825,-4.74667696,2.07E-06,0.000836122,CvsMid
431,plut2.m8.32471,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-1.991283662,0.417301774,-4.771807325,1.83E-06,0.000877092,CvsHigh
432,plut2.m8.32471,GO:0051707,0.049013967,0.994714315,2,33,response to other organism,BP,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-2.015044234,0.424516825,-4.74667696,2.07E-06,0.000836122,CvsMid
433,plut2.m8.32471,GO:0051707,0.049013967,0.994714315,2,33,response to other organism,BP,18,19,11,0,21,12,20,10,10,16,17,10,975,14.36512776,-1.991283662,0.417301774,-4.771807325,1.83E-06,0.000877092,CvsHigh
434,plut2.m8.32950,GO:0060996,0.003081911,0.999934399,2,8,dendritic spine development,BP,12,29,5,9,14,42,28,12,13,8,6,9,2662,16.41448263,-2.105848127,0.491329562,-4.286019593,1.82E-05,0.00527347,CvsHigh
435,plut2.m8.32950,GO:0007010,0.008079152,0.999245921,3,45,cytoskeleton organization,BP,12,29,5,9,14,42,28,12,13,8,6,9,2662,16.41448263,-2.105848127,0.491329562,-4.286019593,1.82E-05,0.00527347,CvsHigh
436,plut2.m8.32950,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,12,29,5,9,14,42,28,12,13,8,6,9,2662,16.41448263,-2.105848127,0.491329562,-4.286019593,1.82E-05,0.00527347,CvsHigh
437,plut2.m8.32950,GO:0045315,0.008068669,1,1,1,positive regulation of compound eye photoreceptor development,BP,12,29,5,9,14,42,28,12,13,8,6,9,2662,16.41448263,-2.105848127,0.491329562,-4.286019593,1.82E-05,0.00527347,CvsHigh
438,plut2.m8.32950,GO:2000047,0.008068669,1,1,1,regulation of cell-cell adhesion mediated by cadherin,BP,12,29,5,9,14,42,28,12,13,8,6,9,2662,16.41448263,-2.105848127,0.491329562,-4.286019593,1.82E-05,0.00527347,CvsHigh
439,plut2.m8.32950,GO:0018105,0.020122829,0.997343127,3,58,peptidyl-serine phosphorylation,BP,12,29,5,9,14,42,28,12,13,8,6,9,2662,16.41448263,-2.105848127,0.491329562,-4.286019593,1.82E-05,0.00527347,CvsHigh
440,plut2.m8.32950,GO:0043408,0.022514127,0.998441324,2,22,regulation of MAPK cascade,BP,12,29,5,9,14,42,28,12,13,8,6,9,2662,16.41448263,-2.105848127,0.491329562,-4.286019593,1.82E-05,0.00527347,CvsHigh
441,plut2.m8.32950,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,12,29,5,9,14,42,28,12,13,8,6,9,2662,16.41448263,-2.105848127,0.491329562,-4.286019593,1.82E-05,0.00527347,CvsHigh
442,plut2.m8.32950,GO:0005912,0.037060493,0.996578409,2,31,adherens junction,CC,12,29,5,9,14,42,28,12,13,8,6,9,2662,16.41448263,-2.105848127,0.491329562,-4.286019593,1.82E-05,0.00527347,CvsHigh
443,plut2.m8.32950,GO:0045792,0.046516114,0.995096762,2,38,negative regulation of cell size,BP,12,29,5,9,14,42,28,12,13,8,6,9,2662,16.41448263,-2.105848127,0.491329562,-4.286019593,1.82E-05,0.00527347,CvsHigh
444,plut2.m8.32950,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,12,29,5,9,14,42,28,12,13,8,6,9,2662,16.41448263,-2.105848127,0.491329562,-4.286019593,1.82E-05,0.00527347,CvsHigh
445,plut2.m8.32953,GO:0006646,0.000504796,0.999996908,2,4,phosphatidylethanolamine biosynthetic process,BP,730,515,136,103,156,482,312,1579,633,600,60,87,813,365.7836359,-1.860931571,0.442015758,-4.210102328,2.55E-05,0.028711624,MidvsHigh
446,plut2.m8.32953,GO:0004305,0.02262127,0.999871446,1,2,ethanolamine kinase activity,MF,730,515,136,103,156,482,312,1579,633,600,60,87,813,365.7836359,-1.860931571,0.442015758,-4.210102328,2.55E-05,0.028711624,MidvsHigh
447,plut2.m8.33084,GO:0042908,0.016151185,0.999065346,2,21,xenobiotic transport,BP,35,47,31,12,26,49,34,32,11,36,12,18,2220,30.80836823,-1.94782431,0.391682474,-4.972967745,6.59E-07,0.000414935,CvsHigh
448,plut2.m8.33084,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,35,47,31,12,26,49,34,32,11,36,12,18,2220,30.80836823,-1.94782431,0.391682474,-4.972967745,6.59E-07,0.000414935,CvsHigh
449,plut2.m8.33084,GO:0140115,0.019975787,0.99869809,2,23,export across plasma membrane,BP,35,47,31,12,26,49,34,32,11,36,12,18,2220,30.80836823,-1.94782431,0.391682474,-4.972967745,6.59E-07,0.000414935,CvsHigh
450,plut2.m8.33084,GO:0015432,0.014573929,0.999204069,2,20,ATPase-coupled bile acid transmembrane transporter activity,MF,35,47,31,12,26,49,34,32,11,36,12,18,2220,30.80836823,-1.94782431,0.391682474,-4.972967745,6.59E-07,0.000414935,CvsHigh
451,plut2.m8.33084,GO:0015431,0.019675104,0.998724302,2,24,ATPase-coupled glutathione S-conjugate transmembrane transporter activity,MF,35,47,31,12,26,49,34,32,11,36,12,18,2220,30.80836823,-1.94782431,0.391682474,-4.972967745,6.59E-07,0.000414935,CvsHigh
452,plut2.m8.33084,GO:0071716,0.018371988,0.998854493,2,23,leukotriene transport,BP,35,47,31,12,26,49,34,32,11,36,12,18,2220,30.80836823,-1.94782431,0.391682474,-4.972967745,6.59E-07,0.000414935,CvsHigh
453,plut2.m8.33367,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,25,22,22,5,55,18,23,10,9,16,42,7,1965,22.14763842,-2.595244666,0.390301882,-6.649326553,2.94E-11,3.48E-08,CvsMid
454,plut2.m8.33367,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,25,22,22,5,55,18,23,10,9,16,42,7,1965,22.14763842,-1.814069143,0.399673711,-4.538875326,5.66E-06,0.002020857,CvsHigh
455,plut2.m8.33367,GO:0005112,0.001256689,0.999942694,3,21,Notch binding,MF,25,22,22,5,55,18,23,10,9,16,42,7,1965,22.14763842,-2.595244666,0.390301882,-6.649326553,2.94E-11,3.48E-08,CvsMid
456,plut2.m8.33367,GO:0005112,0.001256689,0.999942694,3,21,Notch binding,MF,25,22,22,5,55,18,23,10,9,16,42,7,1965,22.14763842,-1.814069143,0.399673711,-4.538875326,5.66E-06,0.002020857,CvsHigh
457,plut2.m8.33377,GO:0003197,0.043206828,0.999291642,1,4,endocardial cushion development,BP,16,30,22,16,25,19,35,11,12,17,17,11,4155,21.46780004,-1.68023545,0.455813869,-3.686231515,0.000227599,0.040333312,CvsHigh
458,plut2.m8.33377,GO:0070487,0.035266334,0.99958153,1,3,monocyte aggregation,BP,16,30,22,16,25,19,35,11,12,17,17,11,4155,21.46780004,-1.68023545,0.455813869,-3.686231515,0.000227599,0.040333312,CvsHigh
459,plut2.m8.33377,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,16,30,22,16,25,19,35,11,12,17,17,11,4155,21.46780004,-1.68023545,0.455813869,-3.686231515,0.000227599,0.040333312,CvsHigh
460,plut2.m8.33379,GO:0019478,0.010441829,1,1,1,D-amino acid catabolic process,BP,14,16,19,0,18,7,15,12,7,11,12,7,1392,12.26004369,-2.185855725,0.491131809,-4.450649877,8.56E-06,0.002447518,CvsMid
461,plut2.m8.33379,GO:0003884,0.010441829,1,1,1,D-amino-acid oxidase activity,MF,14,16,19,0,18,7,15,12,7,11,12,7,1392,12.26004369,-2.185855725,0.491131809,-4.450649877,8.56E-06,0.002447518,CvsMid
462,plut2.m8.33379,GO:0046416,0.0182556,0.999916464,1,2,D-amino acid metabolic process,BP,14,16,19,0,18,7,15,12,7,11,12,7,1392,12.26004369,-2.185855725,0.491131809,-4.450649877,8.56E-06,0.002447518,CvsMid
463,plut2.m8.33535,GO:0001654,0.001623067,0.999918285,3,23,eye development,BP,137,74,33,18,79,101,66,85,62,66,36,29,570,61.01149734,-1.20524184,0.242954485,-4.960772143,7.02E-07,0.000414935,CvsHigh
464,plut2.m8.33535,GO:0014036,0.01839143,1,1,1,neural crest cell fate specification,BP,137,74,33,18,79,101,66,85,62,66,36,29,570,61.01149734,-1.20524184,0.242954485,-4.960772143,7.02E-07,0.000414935,CvsHigh
465,plut2.m8.33535,GO:0021516,0.040894098,0.999435857,1,3,dorsal spinal cord development,BP,137,74,33,18,79,101,66,85,62,66,36,29,570,61.01149734,-1.20524184,0.242954485,-4.960772143,7.02E-07,0.000414935,CvsHigh
466,plut2.m8.33535,GO:0007387,0.01839143,1,1,1,anterior compartment pattern formation,BP,137,74,33,18,79,101,66,85,62,66,36,29,570,61.01149734,-1.20524184,0.242954485,-4.960772143,7.02E-07,0.000414935,CvsHigh
467,plut2.m8.33535,GO:0045944,0.044572701,0.983625155,7,327,positive regulation of transcription by RNA polymerase II,BP,137,74,33,18,79,101,66,85,62,66,36,29,570,61.01149734,-1.20524184,0.242954485,-4.960772143,7.02E-07,0.000414935,CvsHigh
468,plut2.m8.33535,GO:0010971,0.005336525,0.999839009,2,11,positive regulation of G2/M transition of mitotic cell cycle,BP,137,74,33,18,79,101,66,85,62,66,36,29,570,61.01149734,-1.20524184,0.242954485,-4.960772143,7.02E-07,0.000414935,CvsHigh
469,plut2.m8.33535,GO:0007388,0.01839143,1,1,1,posterior compartment specification,BP,137,74,33,18,79,101,66,85,62,66,36,29,570,61.01149734,-1.20524184,0.242954485,-4.960772143,7.02E-07,0.000414935,CvsHigh
470,plut2.m8.33535,GO:0003700,0.045552954,0.988855755,4,129,DNA-binding transcription factor activity,MF,137,74,33,18,79,101,66,85,62,66,36,29,570,61.01149734,-1.20524184,0.242954485,-4.960772143,7.02E-07,0.000414935,CvsHigh
471,plut2.m8.33535,GO:0001779,0.046493989,0.999178589,1,4,natural killer cell differentiation,BP,137,74,33,18,79,101,66,85,62,66,36,29,570,61.01149734,-1.20524184,0.242954485,-4.960772143,7.02E-07,0.000414935,CvsHigh
472,plut2.m8.3398,GO:0030510,0.041205806,0.999356291,1,4,regulation of BMP signaling pathway,BP,42,24,10,5,25,81,30,24,6,26,11,10,1870,24.57191696,-2.300655171,0.484600679,-4.747527748,2.06E-06,0.000930568,CvsHigh
473,plut2.m8.3398,GO:0046552,0.00858916,1,1,1,photoreceptor cell fate commitment,BP,42,24,10,5,25,81,30,24,6,26,11,10,1870,24.57191696,-2.300655171,0.484600679,-4.747527748,2.06E-06,0.000930568,CvsHigh
474,plut2.m8.3398,GO:0040011,0.012369884,0.99864808,3,47,locomotion,BP,42,24,10,5,25,81,30,24,6,26,11,10,1870,24.57191696,-2.300655171,0.484600679,-4.747527748,2.06E-06,0.000930568,CvsHigh
475,plut2.m8.3398,GO:0042670,0.015788386,0.999937596,1,2,retinal cone cell differentiation,BP,42,24,10,5,25,81,30,24,6,26,11,10,1870,24.57191696,-2.300655171,0.484600679,-4.747527748,2.06E-06,0.000930568,CvsHigh
476,plut2.m8.3398,GO:0090100,0.030657231,0.999645296,1,4,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,42,24,10,5,25,81,30,24,6,26,11,10,1870,24.57191696,-2.300655171,0.484600679,-4.747527748,2.06E-06,0.000930568,CvsHigh
477,plut2.m8.3544,GO:0016477,0.002553513,0.999635491,5,96,cell migration,BP,1035,520,242,142,627,644,566,527,690,409,323,206,2073,452.5771807,-1.012999715,0.20722973,-4.888293361,1.02E-06,0.000558155,CvsHigh
478,plut2.m8.3544,GO:0004713,0.002387017,0.999579723,6,145,protein tyrosine kinase activity,MF,1035,520,242,142,627,644,566,527,690,409,323,206,2073,452.5771807,-1.012999715,0.20722973,-4.888293361,1.02E-06,0.000558155,CvsHigh
479,plut2.m8.3544,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,1035,520,242,142,627,644,566,527,690,409,323,206,2073,452.5771807,-1.012999715,0.20722973,-4.888293361,1.02E-06,0.000558155,CvsHigh
480,plut2.m8.3544,GO:0040012,0.008186208,0.999683944,2,13,regulation of locomotion,BP,1035,520,242,142,627,644,566,527,690,409,323,206,2073,452.5771807,-1.012999715,0.20722973,-4.888293361,1.02E-06,0.000558155,CvsHigh
481,plut2.m8.3544,GO:0030324,0.01541899,0.998160495,3,55,lung development,BP,1035,520,242,142,627,644,566,527,690,409,323,206,2073,452.5771807,-1.012999715,0.20722973,-4.888293361,1.02E-06,0.000558155,CvsHigh
482,plut2.m8.3544,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,1035,520,242,142,627,644,566,527,690,409,323,206,2073,452.5771807,-1.012999715,0.20722973,-4.888293361,1.02E-06,0.000558155,CvsHigh
483,plut2.m8.3544,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,1035,520,242,142,627,644,566,527,690,409,323,206,2073,452.5771807,-1.012999715,0.20722973,-4.888293361,1.02E-06,0.000558155,CvsHigh
484,plut2.m8.3794,GO:0071013,0.034826319,0.996901479,2,29,catalytic step 2 spliceosome,CC,198,269,185,30,405,180,265,127,84,245,270,144,1719,218.662426,-2.298525002,0.192107036,-11.96481428,5.43E-33,2.78E-29,CvsHigh
485,plut2.m8.3794,GO:0071013,0.034826319,0.996901479,2,29,catalytic step 2 spliceosome,CC,198,269,185,30,405,180,265,127,84,245,270,144,1719,218.662426,-2.531134784,0.192526429,-13.14694713,1.77E-39,1.36E-35,CvsMid
486,plut2.m8.3794,GO:0007017,0.037597796,0.996519839,2,28,microtubule-based process,BP,198,269,185,30,405,180,265,127,84,245,270,144,1719,218.662426,-2.298525002,0.192107036,-11.96481428,5.43E-33,2.78E-29,CvsHigh
487,plut2.m8.3794,GO:0007017,0.037597796,0.996519839,2,28,microtubule-based process,BP,198,269,185,30,405,180,265,127,84,245,270,144,1719,218.662426,-2.531134784,0.192526429,-13.14694713,1.77E-39,1.36E-35,CvsMid
488,plut2.m8.3794,GO:0071005,0.037310701,0.996554312,2,29,U2-type precatalytic spliceosome,CC,198,269,185,30,405,180,265,127,84,245,270,144,1719,218.662426,-2.298525002,0.192107036,-11.96481428,5.43E-33,2.78E-29,CvsHigh
489,plut2.m8.3794,GO:0071005,0.037310701,0.996554312,2,29,U2-type precatalytic spliceosome,CC,198,269,185,30,405,180,265,127,84,245,270,144,1719,218.662426,-2.531134784,0.192526429,-13.14694713,1.77E-39,1.36E-35,CvsMid
490,plut2.m8.3794,GO:0007010,0.008079152,0.999245921,3,45,cytoskeleton organization,BP,198,269,185,30,405,180,265,127,84,245,270,144,1719,218.662426,-2.298525002,0.192107036,-11.96481428,5.43E-33,2.78E-29,CvsHigh
491,plut2.m8.3794,GO:0007010,0.008079152,0.999245921,3,45,cytoskeleton organization,BP,198,269,185,30,405,180,265,127,84,245,270,144,1719,218.662426,-2.531134784,0.192526429,-13.14694713,1.77E-39,1.36E-35,CvsMid
492,plut2.m8.4590,GO:0005537,0.002664369,0.99994736,2,8,mannose binding,MF,16,71,31,5,69,37,39,8,10,40,35,23,775,36.56802671,-3.340669318,0.348817139,-9.577136404,9.98E-22,3.07E-18,CvsHigh
493,plut2.m8.4590,GO:0005537,0.002664369,0.99994736,2,8,mannose binding,MF,16,71,31,5,69,37,39,8,10,40,35,23,775,36.56802671,-3.27457139,0.35346645,-9.264164638,1.97E-20,6.04E-17,CvsMid
494,plut2.m8.4878,GO:0198738,0.035091823,0.999585695,1,3,cell-cell signaling by wnt,BP,32,44,15,0,65,37,36,43,26,24,35,21,1085,31.24581089,-1.674559072,0.413815059,-4.046636381,5.20E-05,0.01191564,CvsHigh
495,plut2.m8.4878,GO:0198738,0.035091823,0.999585695,1,3,cell-cell signaling by wnt,BP,32,44,15,0,65,37,36,43,26,24,35,21,1085,31.24581089,-1.763739655,0.417008213,-4.229508199,2.34E-05,0.005622696,CvsMid
496,plut2.m8.5234,GO:0001879,0.007138708,1,1,1,detection of yeast,BP,14,13,14,0,10,9,16,8,9,8,17,11,5391,11.87011634,-2.237768204,0.506064976,-4.421898989,9.78E-06,0.002684408,CvsMid
497,plut2.m8.5234,GO:0001872,0.030697457,0.999683598,1,3,(1->3)-beta-D-glucan binding,MF,14,13,14,0,10,9,16,8,9,8,17,11,5391,11.87011634,-2.237768204,0.506064976,-4.421898989,9.78E-06,0.002684408,CvsMid
498,plut2.m8.5234,GO:0005537,0.002664369,0.99994736,2,8,mannose binding,MF,14,13,14,0,10,9,16,8,9,8,17,11,5391,11.87011634,-2.237768204,0.506064976,-4.421898989,9.78E-06,0.002684408,CvsMid
499,plut2.m8.5800,GO:0003674,0.021909676,0.993808785,6,219,molecular_function,MF,12,45,30,16,36,20,40,32,9,22,30,19,1788,29.15946264,-1.834256806,0.471405635,-3.89103708,9.98E-05,0.018258134,CvsMid
500,plut2.m8.5800,GO:0003674,0.021909676,0.993808785,6,219,molecular_function,MF,12,45,30,16,36,20,40,32,9,22,30,19,1788,29.15946264,-1.697952149,0.468854412,-3.621491247,0.00029291,0.048919107,CvsHigh
501,plut2.m8.5800,GO:0005575,0.03213374,0.991382616,5,178,cellular_component,CC,12,45,30,16,36,20,40,32,9,22,30,19,1788,29.15946264,-1.834256806,0.471405635,-3.89103708,9.98E-05,0.018258134,CvsMid
502,plut2.m8.5800,GO:0005575,0.03213374,0.991382616,5,178,cellular_component,CC,12,45,30,16,36,20,40,32,9,22,30,19,1788,29.15946264,-1.697952149,0.468854412,-3.621491247,0.00029291,0.048919107,CvsHigh
503,plut2.m8.5923,GO:0043388,0.002776444,0.999946059,2,7,positive regulation of DNA binding,BP,179,12,7,66,20,16,10,191,133,10,16,8,870,37.22394356,2.278771841,0.315977018,7.211827799,5.52E-13,8.48E-10,CvsMid
504,plut2.m8.5923,GO:0043388,0.002776444,0.999946059,2,7,positive regulation of DNA binding,BP,179,12,7,66,20,16,10,191,133,10,16,8,870,37.22394356,2.547484568,0.316502141,8.048869951,8.36E-16,1.83E-12,CvsHigh
505,plut2.m8.6795,GO:0004563,0.044351159,0.999253253,1,4,beta-N-acetylhexosaminidase activity,MF,16,20,17,6,23,13,16,19,14,15,16,6,2787,15.4437727,-1.419195361,0.384432715,-3.691661258,0.000222794,0.034232309,CvsMid
506,plut2.m8.7161,GO:0000245,0.004146037,0.999892024,2,10,spliceosomal complex assembly,BP,40,16,14,5,35,16,20,20,15,11,21,8,1331,17.21351617,-1.274131318,0.350967098,-3.630344055,0.000283044,0.041816981,CvsMid
507,plut2.m8.7161,GO:0089701,0.010843528,1,1,1,U2AF,CC,40,16,14,5,35,16,20,20,15,11,21,8,1331,17.21351617,-1.274131318,0.350967098,-3.630344055,0.000283044,0.041816981,CvsMid
508,plut2.m8.7161,GO:0030628,0.025496805,0.999782242,1,3,pre-mRNA 3'-splice site binding,MF,40,16,14,5,35,16,20,20,15,11,21,8,1331,17.21351617,-1.274131318,0.350967098,-3.630344055,0.000283044,0.041816981,CvsMid
509,plut2.m8.7161,GO:0005689,0.00691923,0.999757953,2,12,U12-type spliceosomal complex,CC,40,16,14,5,35,16,20,20,15,11,21,8,1331,17.21351617,-1.274131318,0.350967098,-3.630344055,0.000283044,0.041816981,CvsMid
510,plut2.m8.7220,GO:0005575,0.03213374,0.991382616,5,178,cellular_component,CC,12,40,20,0,34,43,31,7,6,32,20,20,351,25.77782991,-3.2910173,0.415131421,-7.927651671,2.23E-15,5.72E-12,CvsMid
511,plut2.m8.7220,GO:0005575,0.03213374,0.991382616,5,178,cellular_component,CC,12,40,20,0,34,43,31,7,6,32,20,20,351,25.77782991,-3.695337224,0.40441763,-9.137428616,6.40E-20,1.64E-16,CvsHigh
512,plut2.m8.7220,GO:0003674,0.021909676,0.993808785,6,219,molecular_function,MF,12,40,20,0,34,43,31,7,6,32,20,20,351,25.77782991,-3.2910173,0.415131421,-7.927651671,2.23E-15,5.72E-12,CvsMid
513,plut2.m8.7220,GO:0003674,0.021909676,0.993808785,6,219,molecular_function,MF,12,40,20,0,34,43,31,7,6,32,20,20,351,25.77782991,-3.695337224,0.40441763,-9.137428616,6.40E-20,1.64E-16,CvsHigh
514,plut2.m8.7220,GO:0001881,0.045353198,0.999304691,1,3,receptor recycling,BP,12,40,20,0,34,43,31,7,6,32,20,20,351,25.77782991,-3.2910173,0.415131421,-7.927651671,2.23E-15,5.72E-12,CvsMid
515,plut2.m8.7220,GO:0001881,0.045353198,0.999304691,1,3,receptor recycling,BP,12,40,20,0,34,43,31,7,6,32,20,20,351,25.77782991,-3.695337224,0.40441763,-9.137428616,6.40E-20,1.64E-16,CvsHigh
516,plut2.m8.7302,GO:0008046,0.041584192,0.999301092,1,5,axon guidance receptor activity,MF,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
517,plut2.m8.7302,GO:0001771,0.033421402,0.999577949,1,4,immunological synapse formation,BP,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
518,plut2.m8.7302,GO:0021952,0.024737015,0.999795098,1,3,central nervous system projection neuron axonogenesis,BP,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
519,plut2.m8.7302,GO:0014719,0.022253364,0.999834365,1,3,skeletal muscle satellite cell activation,BP,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
520,plut2.m8.7302,GO:0005004,0.007039714,1,1,1,GPI-linked ephrin receptor activity,MF,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
521,plut2.m8.7302,GO:0021631,0.0151344,0.999942678,1,2,optic nerve morphogenesis,BP,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
522,plut2.m8.7302,GO:0097161,0.007039714,1,1,1,DH domain binding,MF,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
523,plut2.m8.7302,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
524,plut2.m8.7302,GO:2001108,0.007039714,1,1,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
525,plut2.m8.7302,GO:1902723,0.007039714,1,1,1,negative regulation of skeletal muscle satellite cell proliferation,BP,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
526,plut2.m8.7302,GO:0005003,0.004406729,0.999887287,2,8,ephrin receptor activity,MF,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
527,plut2.m8.7302,GO:0005005,0.007039714,1,1,1,transmembrane-ephrin receptor activity,MF,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
528,plut2.m8.7302,GO:0032433,0.023025089,0.999822615,1,3,filopodium tip,CC,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
529,plut2.m8.7302,GO:0007169,0.044255717,0.995481018,2,34,transmembrane receptor protein tyrosine kinase signaling pathway,BP,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
530,plut2.m8.7302,GO:1902725,0.007039714,1,1,1,negative regulation of satellite cell differentiation,BP,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
531,plut2.m8.7302,GO:0004713,0.002387017,0.999579723,6,145,protein tyrosine kinase activity,MF,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
532,plut2.m8.7302,GO:0097155,0.016548984,0.999931412,1,2,fasciculation of sensory neuron axon,BP,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
533,plut2.m8.7302,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
534,plut2.m8.7302,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
535,plut2.m8.7302,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,393,83,77,146,218,33,101,393,241,51,112,55,9788,128.912059,1.145686845,0.288747978,3.967774435,7.25E-05,0.01548172,CvsHigh
536,plut2.m8.7539,GO:0034998,0.027716846,0.999806503,1,2,oligosaccharyltransferase I complex,CC,12,9,17,8,18,22,13,12,1,15,19,9,873,14.81456266,-2.142932314,0.542754714,-3.948251872,7.87E-05,0.015254964,CvsMid
537,plut2.m8.7555,GO:0016477,0.002553513,0.999635491,5,96,cell migration,BP,182,286,200,47,166,131,277,99,76,155,221,236,2577,203.5556683,-2.513841592,0.348453804,-7.214275074,5.42E-13,8.48E-10,CvsMid
538,plut2.m8.7555,GO:0016477,0.002553513,0.999635491,5,96,cell migration,BP,182,286,200,47,166,131,277,99,76,155,221,236,2577,203.5556683,-2.123895153,0.348550133,-6.093514114,1.10E-09,9.98E-07,CvsHigh
539,plut2.m8.8087,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,36,51,19,10,67,78,43,27,29,37,37,26,348,40.53359827,-1.781861996,0.316435706,-5.631039615,1.79E-08,1.25E-05,CvsMid
540,plut2.m8.8087,GO:0005576,0.043876975,0.979067108,12,695,extracellular region,CC,36,51,19,10,67,78,43,27,29,37,37,26,348,40.53359827,-2.104678855,0.307688926,-6.840281457,7.90E-12,1.10E-08,CvsHigh
541,plut2.m8.8613,GO:0090166,0.042042746,0.999329634,1,4,Golgi disassembly,BP,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
542,plut2.m8.8613,GO:0030332,0.006579192,0.999770985,2,14,cyclin binding,MF,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
543,plut2.m8.8613,GO:0005524,0.018435581,0.991451998,15,833,ATP binding,MF,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
544,plut2.m8.8613,GO:0097125,0.007511118,1,1,1,cyclin B1-CDK1 complex,CC,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
545,plut2.m8.8613,GO:0014038,0.007511118,1,1,1,regulation of Schwann cell differentiation,BP,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
546,plut2.m8.8613,GO:0042752,0.031423157,0.99736536,2,27,regulation of circadian rhythm,BP,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
547,plut2.m8.8613,GO:0072686,0.03858638,0.993418674,3,74,mitotic spindle,CC,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
548,plut2.m8.8613,GO:0018105,0.020122829,0.997343127,3,58,peptidyl-serine phosphorylation,BP,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
549,plut2.m8.8613,GO:0042542,0.024208775,0.998234843,2,27,response to hydrogen peroxide,BP,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
550,plut2.m8.8613,GO:0010971,0.005336525,0.999839009,2,11,positive regulation of G2/M transition of mitotic cell cycle,BP,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
551,plut2.m8.8613,GO:0004672,0.011017633,0.996109818,10,439,protein kinase activity,MF,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
552,plut2.m8.8613,GO:0035173,0.014836392,0.999944922,1,2,histone kinase activity,MF,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
553,plut2.m8.8613,GO:0007344,0.021874217,0.999879843,1,2,pronuclear fusion,BP,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
554,plut2.m8.8613,GO:1905448,0.017024887,0.999927393,1,2,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
555,plut2.m8.8613,GO:0016477,0.002553513,0.999635491,5,96,cell migration,BP,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
556,plut2.m8.8613,GO:0006468,0.00984472,0.996583282,10,425,protein phosphorylation,BP,71,22,17,8,101,13,16,44,49,18,72,14,3486,33.11782698,-1.452190361,0.402946979,-3.603924177,0.000313449,0.045435252,CvsMid
557,plut2.m8.92,GO:0007017,0.037597796,0.996519839,2,28,microtubule-based process,BP,1483,721,594,395,848,711,695,1186,886,662,632,419,2271,731.3795336,-0.578753009,0.141485417,-4.09054884,4.30E-05,0.010331848,CvsHigh
558,plut2.m8.92,GO:0007017,0.037597796,0.996519839,2,28,microtubule-based process,BP,1483,721,594,395,848,711,695,1186,886,662,632,419,2271,731.3795336,-0.65332451,0.142026472,-4.600019294,4.22E-06,0.001442438,CvsMid
559,plut2.m8.92,GO:0007010,0.008079152,0.999245921,3,45,cytoskeleton organization,BP,1483,721,594,395,848,711,695,1186,886,662,632,419,2271,731.3795336,-0.578753009,0.141485417,-4.09054884,4.30E-05,0.010331848,CvsHigh
560,plut2.m8.92,GO:0007010,0.008079152,0.999245921,3,45,cytoskeleton organization,BP,1483,721,594,395,848,711,695,1186,886,662,632,419,2271,731.3795336,-0.65332451,0.142026472,-4.600019294,4.22E-06,0.001442438,CvsMid
561,plut2.m8.9273,GO:0060576,0.032689766,0.999596352,1,4,intestinal epithelial cell development,BP,22,23,23,8,30,16,13,23,10,12,19,9,3513,17.93916732,-1.628173656,0.374927739,-4.342633227,1.41E-05,0.003605271,CvsMid
562,plut2.m8.9273,GO:0010454,0.007493634,1,1,1,negative regulation of cell fate commitment,BP,22,23,23,8,30,16,13,23,10,12,19,9,3513,17.93916732,-1.628173656,0.374927739,-4.342633227,1.41E-05,0.003605271,CvsMid
563,plut2.m8.9273,GO:0010455,0.007493634,1,1,1,positive regulation of cell fate commitment,BP,22,23,23,8,30,16,13,23,10,12,19,9,3513,17.93916732,-1.628173656,0.374927739,-4.342633227,1.41E-05,0.003605271,CvsMid
564,plut2.m8.9273,GO:0003700,0.045552954,0.988855755,4,129,DNA-binding transcription factor activity,MF,22,23,23,8,30,16,13,23,10,12,19,9,3513,17.93916732,-1.628173656,0.374927739,-4.342633227,1.41E-05,0.003605271,CvsMid
565,plut2.m8.9273,GO:0045944,0.044572701,0.983625155,7,327,positive regulation of transcription by RNA polymerase II,BP,22,23,23,8,30,16,13,23,10,12,19,9,3513,17.93916732,-1.628173656,0.374927739,-4.342633227,1.41E-05,0.003605271,CvsMid
566,plut2.m8.9273,GO:0060480,0.015449775,0.999940255,1,2,lung goblet cell differentiation,BP,22,23,23,8,30,16,13,23,10,12,19,9,3513,17.93916732,-1.628173656,0.374927739,-4.342633227,1.41E-05,0.003605271,CvsMid
567,plut2.m8.9923,GO:0098885,0.037075838,0.999479788,1,4,modification of postsynaptic actin cytoskeleton,BP,138,71,27,20,63,43,82,60,58,44,51,31,1035,53.17523148,-0.955282539,0.261477351,-3.653404538,0.000258786,0.044180526,CvsHigh
568,plut2.m8.9923,GO:0035046,0.020334925,0.999896241,1,2,pronuclear migration,BP,138,71,27,20,63,43,82,60,58,44,51,31,1035,53.17523148,-0.955282539,0.261477351,-3.653404538,0.000258786,0.044180526,CvsHigh
569,plut2.m8.9923,GO:0008360,0.023132412,0.998365526,2,24,regulation of cell shape,BP,138,71,27,20,63,43,82,60,58,44,51,31,1035,53.17523148,-0.955282539,0.261477351,-3.653404538,0.000258786,0.044180526,CvsHigh
570,plut2.m8.9923,GO:0030027,0.023672016,0.996676695,3,58,lamellipodium,CC,138,71,27,20,63,43,82,60,58,44,51,31,1035,53.17523148,-0.955282539,0.261477351,-3.653404538,0.000258786,0.044180526,CvsHigh
571,plut2.m8.9923,GO:0030032,0.008254256,0.999676846,2,14,lamellipodium assembly,BP,138,71,27,20,63,43,82,60,58,44,51,31,1035,53.17523148,-0.955282539,0.261477351,-3.653404538,0.000258786,0.044180526,CvsHigh
572,plut2.m8.9923,GO:0031209,0.030100533,0.99977151,1,2,SCAR complex,CC,138,71,27,20,63,43,82,60,58,44,51,31,1035,53.17523148,-0.955282539,0.261477351,-3.653404538,0.000258786,0.044180526,CvsHigh
573,plut2.m8.9923,GO:0016601,0.044921995,0.999183261,1,5,Rac protein signal transduction,BP,138,71,27,20,63,43,82,60,58,44,51,31,1035,53.17523148,-0.955282539,0.261477351,-3.653404538,0.000258786,0.044180526,CvsHigh
574,plut2.m8.9923,GO:2000601,0.025714804,0.999833618,1,2,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,138,71,27,20,63,43,82,60,58,44,51,31,1035,53.17523148,-0.955282539,0.261477351,-3.653404538,0.000258786,0.044180526,CvsHigh
575,plut2.m8.9923,GO:0072673,0.013296085,1,1,1,lamellipodium morphogenesis,BP,138,71,27,20,63,43,82,60,58,44,51,31,1035,53.17523148,-0.955282539,0.261477351,-3.653404538,0.000258786,0.044180526,CvsHigh
576,plut2.m8.9923,GO:0031643,0.03016937,0.999770456,1,2,positive regulation of myelination,BP,138,71,27,20,63,43,82,60,58,44,51,31,1035,53.17523148,-0.955282539,0.261477351,-3.653404538,0.000258786,0.044180526,CvsHigh
577,plut2.m8.9923,GO:0071933,0.035973485,0.999510494,1,4,Arp2/3 complex binding,MF,138,71,27,20,63,43,82,60,58,44,51,31,1035,53.17523148,-0.955282539,0.261477351,-3.653404538,0.000258786,0.044180526,CvsHigh